[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,879,949,993,1150,1208,1308,1437,1484],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":776,"relativeEntities":777,"slug":778,"properties":779,"entityType":688,"verifyStatus":25,"verifyTime":776,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":786,"fullTextUrl":26,"authors":787,"publicationType":747,"publisherRelationship":863,"citationCount":26,"citationInfo":26,"publishDate":877,"publishYear":878,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"02a8e3ee-d8d6-41d8-86f5-5144853a9b0a","2024-01-11T06:50:21.574+00:00","2024-12-12T00:55:43.470+00:00",[],"Estrategia-de-diagn%C3%B3stico-prenatal-y-tratamiento-de-las-enfermedades-relacionadas-con-los-embarazos-m%C3%BAltiples",{"references":780,"title":782,"doi":784},{"VOID":781},"Evans, 2010, Screening and testing in multiples, Clin Lab Med, 30, 643, 10.1016\u002Fj.cll.2010.05.005\nVayssiere, 2010, Twin pregnancies: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF), Eur J Obstet Gynecol Reprod Biol, 156, 12, 10.1016\u002Fj.ejogrb.2010.12.045\nCuckle, 1998, Down's syndrome screening in twins, J Med Screen, 5, 3, 10.1136\u002Fjms.5.1.3\nSebire, 1997, The prevalence and consequences of missed abortion in twin pregnancies at 10 to 14 weeks of gestation, Br J Obstet Gynaecol, 104, 847, 10.1111\u002Fj.1471-0528.1997.tb12033.x\nSebire, 1996, Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation, Br J Obstet Gynaecol, 103, 999, 10.1111\u002Fj.1471-0528.1996.tb09550.x\nOdibo, 2003, Screening for aneuploidy in twins and higher-order multiples: is first-trimester nuchal translucency the solution?, Obstet Gynecol Surv, 58, 609, 10.1097\u002F01.OGX.0000082369.30519.A8\nGlinianaia, 2008, Congenital anomalies in twins: a register-based study, Hum Reprod, 23, 1306, 10.1093\u002Fhumrep\u002Fden104\nBryan, 1987, Congenital anomalies in twins, Baillieres Clin Obstet Gynaecol, 1, 697, 10.1016\u002FS0950-3552(87)80012-3\nLewi, 2008, The outcome of monochorionic diamniotic twin gestations in the era of invasive fetal therapy: a prospective cohort study, Am J Obstet Gynecol, 199, 514, 10.1016\u002Fj.ajog.2008.03.050\nSepulveda, 2005, Discordant lower urinary tract obstruction in early twin gestations: management and outcome, Obstet Gynecol, 106, 797, 10.1097\u002F01.AOG.0000175833.65983.ee\nWeber, 2010, Genetics and developmental pathology of twinning, Semin Fetal Neonatal Med, 15, 313, 10.1016\u002Fj.siny.2010.06.002\nWeisz, 2004, Tailored management of twin reversed arterial perfusion (trap) sequence, Ultrasound Obstet Gynecol, 23, 451, 10.1002\u002Fuog.1040\nNakata, 2008, Fetoscopic laser photocoagulation of placental communicating vessels for twin-reversed arterial perfusion sequence, J Obstet Gynaecol Res, 34, 649, 10.1111\u002Fj.1447-0756.2008.00901.x\nDiehl, 2007, Selective cord coagulation in acardiac twins, Semin Fetal Neonatal Med, 12, 458, 10.1016\u002Fj.siny.2007.06.008\nRossi, 2008, Laser therapy and serial amnioreduction as treatment for twin-twin transfusion syndrome: a meta-analysis and review of literature, Am J Obstet Gynecol, 198, 147, 10.1016\u002Fj.ajog.2007.09.043\nRoman, 2010, Selective reduction in complicated monochorionic pregnancies: radiofrequency ablation vs. bipolar cord coagulation, Ultrasound Obstet Gynecol, 36, 37, 10.1002\u002Fuog.7567\nDelabaere, 2013, Suivi pédiatrique de 30 grossesses gémellaires monochoriales consécutives traitées par foeticide sélectif, Gynecol Obstet Fertil, 41, 85, 10.1016\u002Fj.gyobfe.2012.12.007\nYamamoto, 2005, Incidence and impact of perioperative complications in 175 fetoscopy-guided laser coagulations of chorionic plate anastomoses in fetofetal transfusion syndrome before 26 weeks of gestation, Am J Obstet Gynecol, 193, 1110, 10.1016\u002Fj.ajog.2005.07.003\nQuintero, 1999, Staging of twin-twin transfusion syndrome, J Perinatol, 19, 550, 10.1038\u002Fsj.jp.7200292\nQuintero, 2003, Stage-based treatment of twin-twin transfusion syndrome, Am J Obstet Gynecol, 188, 1333, 10.1067\u002Fmob.2003.292\nHuber, 2006, Stage-related outcome in twin-twin transfusion syndrome treated by fetoscopic laser coagulation, Obstet Gynecol, 108, 333, 10.1097\u002F01.AOG.0000225945.17022.6b\nHarkness, 2005, Twin-twin transfusion syndrome: where do we go from here?, Semin Perinatol, 29, 296, 10.1053\u002Fj.semperi.2005.10.001\nRoberts, 2008, Interventions for twin-twin transfusion syndrome: a Cochrane review, Ultrasound Obstet Gynecol, 31, 701, 10.1002\u002Fuog.5328\nDelabaere, 2011, Résultats favorables d’une équipe émergente dans le traitement du syndrome transfuseur–transfusé par photocoagulation-laser, Gynecol Obstet Fertil, 39, 482, 10.1016\u002Fj.gyobfe.2011.02.016\nSlaghekke, 2010, Twin anemia-polycythemia sequence: diagnostic criteria, classification, perinatal management and outcome, Fetal Diagn Ther, 27, 181, 10.1159\u002F000304512\nLopriore, 2008, Fetal and neonatal haematological complications in monochorionic twins, Semin Fetal Neonatal Med, 13, 231, 10.1016\u002Fj.siny.2008.02.002\nLopriore, 2009, Residual anastomoses in twin-to-twin transfusion syndrome treated with selective fetoscopic laser surgery: localization, size, and consequences, Am J Obstet Gynecol, 201, 66, 10.1016\u002Fj.ajog.2009.01.010\nRobyr, 2006, Prevalence and management of late fetal complications following successful selective laser coagulation of chorionic plate anastomoses in twin-to-twin transfusion syndrome, Am J Obstet Gynecol, 194, 796, 10.1016\u002Fj.ajog.2005.08.069\nLewi, 2006, Pregnancy and infant outcome of 80 consecutive cord coagulations in complicated monochorionic multiple pregnancies, Am J Obstet Gynecol, 194, 782, 10.1016\u002Fj.ajog.2005.09.013\nHabli, 2009, Incidence of complications in twin-twin transfusion syndrome after selective fetoscopic laser photocoagulation: a single-center experience, Am J Obstet Gynecol, 201, 417, 10.1016\u002Fj.ajog.2009.07.046\nRussell, 2007, Intrauterine growth restriction in monochorionic twins, Semin Fetal Neonatal Med, 12, 439, 10.1016\u002Fj.siny.2007.06.004\nChang, 2009, Clinical outcome and placental territory ratio of monochorionic twin pregnancies and selective intrauterine growth restriction with different types of umbilical artery Doppler, Prenat Diagn, 29, 253, 10.1002\u002Fpd.2193\nDenbow, 2000, Placental angioarchitecture in monochorionic twin pregnancies: relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome, Am J Obstet Gynecol, 182, 417, 10.1016\u002FS0002-9378(00)70233-X\nLeduc, 2005, Persistance of adverse obstetric and neonatal outcomes in monochorionic twins after exclusion of disorders unique to monochorionic placentation, Am J Obstet Gynecol, 193, 1670, 10.1016\u002Fj.ajog.2005.04.007\nAcosta-Rojas, 2007, Twin chorionicity and the risk of adverse perinatal outcome, Int J Gynaecol Obstet, 96, 98, 10.1016\u002Fj.ijgo.2006.11.002\nGratacos, 2004, Prevalence of neurological damage in monochorionic twins with selective intrauterine growth restriction and intermittent absent or reversed end-diastolic umbilical artery flow, Ultrasound Obstet Gynecol, 24, 159, 10.1002\u002Fuog.1105\nIshii, 2009, Perinatal outcome of monochorionic twins with selective intrauterine growth restriction and different types of umbilical artery Doppler under expectant management, Fetal Diagn Ther, 26, 157, 10.1159\u002F000253880\nValsky, 2010, Selective intrauterine growth restriction in monochorionic twins: pathophysiology, diagnostic approach and management dilemmas, Semin Fetal Neonatal Med, 15, 342, 10.1016\u002Fj.siny.2010.07.002\nGratacos, 2007, A classification system for selective intrauterine growth restriction in monochorionic pregnancies according to umbilical artery Doppler flow in the smaller twin, Ultrasound Obstet Gynecol, 30, 28, 10.1002\u002Fuog.4046\nAxt, 1999, Maternal and neonatal outcome of twin pregnancies complicated by single fetal death, J Perinat Med, 27, 221, 10.1515\u002FJPM.1999.031\nLee, 2008, Twin chorionicity and the risk of stillbirth, Obstet Gynecol, 111, 301, 10.1097\u002FAOG.0b013e318160d65d\nOng, 2006, Prognosis for the co-twin following single-twin death: a systematic review, Bjog, 113, 992, 10.1111\u002Fj.1471-0528.2006.01027.x\nWoo, 2000, Single foetal death in twin pregnancies: review of the maternal and neonatal outcomes and management, Hong Kong Med J, 6, 293\nvan Heteren, 1998, Risk for surviving twin after fetal death of co-twin in twin-twin transfusion syndrome, Obstet Gynecol, 92, 215, 10.1016\u002FS0029-7844(98)00159-8\nBejar, 1990, Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations, Am J Obstet Gynecol, 162, 1230, 10.1016\u002F0002-9378(90)90024-2\nNicolini, 1999, Single intrauterine death in monochorionic twin pregnancies, Ultrasound Obstet Gynecol, 14, 297, 10.1046\u002Fj.1469-0705.1999.14050297.x\nSchinzel, 1979, Monozygotic twinning and structural defects, J Pediatr, 95, 921, 10.1016\u002FS0022-3476(79)80278-4\nMoore, 1969, Intrauterine disseminated intravascular coagulation: a syndrome of multiple pregnancy with a dead twin fetus, J Pediatr, 74, 523, 10.1016\u002FS0022-3476(69)80034-X\nWeisz, 2005, Invasive diagnostic procedures in twin pregnancies, Prenat Diagn, 25, 751, 10.1002\u002Fpd.1263\nNieuwint, 1999, “Identical” twins with discordant karyotypes, Prenat Diagn, 19, 72, 10.1002\u002F(SICI)1097-0223(199901)19:1\u003C72::AID-PD465>3.0.CO;2-V\nToth-Pal, 2004, Genetic amniocentesis in multiple pregnancy, Fetal Diagn Ther, 19, 138, 10.1159\u002F000075138\nMujezinovic, 2007, Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review, Obstet Gynecol, 110, 687, 10.1097\u002F01.AOG.0000278820.54029.e3\nDommergues, 1991, Embryo reduction in multifetal pregnancies after infertility therapy: obstetrical risks and perinatal benefits are related to operative strategy, Fertil Steril, 55, 805, 10.1016\u002FS0015-0282(16)54252-6\nEvans, 1994, Transabdominal versus transcervical and transvaginal multifetal pregnancy reduction: international collaborative experience of more than one thousand cases, Am J Obstet Gynecol, 170, 902, 10.1016\u002FS0002-9378(94)70306-X\nWapner, 1990, Selective reduction of multifetal pregnancies, Lancet, 335, 90, 10.1016\u002F0140-6736(90)90550-O\nSentilhes, 2008, Multifetal pregnancy reduction: indications, technical aspects and psychological impact, Presse Med, 37, 295, 10.1016\u002Fj.lpm.2007.05.016\nSenat, 2002, Funipuncture for fetocide in late termination of pregnancy, Prenat Diagn, 22, 354, 10.1002\u002Fpd.290\nBhide, 2002, Comparison of feticide carried out by cordocentesis versus cardiac puncture, Ultrasound Obstet Gynecol, 20, 230, 10.1046\u002Fj.1469-0705.2002.00797.x\nSenat, 2003, The use of lidocaine for fetocide in late termination of pregnancy, Bjog, 110, 296, 10.1046\u002Fj.1471-0528.2003.02217.x\nNielsen, 1991, Analgesic efficacy of low doses of intravenously administered lidocaine on experimental laser-induced pain: a placebo controlled study, Reg Anesth, 16, 28\nRossi, 2009, Umbilical cord occlusion for selective feticide in complicated monochorionic twins: a systematic review of literature, Am J Obstet Gynecol, 200, 123, 10.1016\u002Fj.ajog.2008.08.039\nDelabaere, 2013, Suivi pédiatrique de 30 grossesses gémellaires monochoriales consécutives traitées par fœticide sélectif, Gynecol Obstet Fertil, 41, 85, 10.1016\u002Fj.gyobfe.2012.12.007",{"ES":783},"Estrategia de diagnóstico prenatal y tratamiento de las enfermedades relacionadas con los embarazos múltiples",{"VOID":785},"10.1016\u002Fs1283-081x(13)65365-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X13653655",[788,803,815,827,839,851],{"id":789,"sortIndex":36,"researcher":26,"roles":790,"affiliations":791,"properties":800},"a6572e51-5aa5-4115-a749-b8be236a9f71",[696],[792],{"id":26,"sortIndex":36,"affiliation":793,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":796,"slug":26,"properties":797,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"3677a859-5b95-42dd-85d4-27d0c50a01c8","2024-01-11T06:50:21.681+00:00",[],{"title":798},{"VI":799},"Pôle gynéco-obstétrique-reproduction humaine, Centre hospitalier universitaire de Clermont-Ferrand, Centre hospitalier universitaire Estaing, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France",{"title":801},{"VI":802},"A. Delabaere",{"id":804,"sortIndex":111,"researcher":26,"roles":805,"affiliations":806,"properties":812},"96b7792f-c31e-4cf1-a02e-3f39936930c8",[696],[807],{"id":26,"sortIndex":36,"affiliation":808,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":809,"slug":26,"properties":810,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":811},{"VI":799},{"title":813},{"VI":814},"D. Lémery",{"id":816,"sortIndex":114,"researcher":26,"roles":817,"affiliations":818,"properties":824},"caa7839d-08a4-44d3-8caf-161f5aa1e31b",[696],[819],{"id":26,"sortIndex":36,"affiliation":820,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":821,"slug":26,"properties":822,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":823},{"VI":799},{"title":825},{"VI":826},"F. Desvignes",{"id":828,"sortIndex":59,"researcher":26,"roles":829,"affiliations":830,"properties":836},"ded6f25d-5999-4755-a55e-a0f662dd5de9",[696],[831],{"id":26,"sortIndex":36,"affiliation":832,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":833,"slug":26,"properties":834,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":835},{"VI":799},{"title":837},{"VI":838},"H. Laurichesse-Delmas",{"id":840,"sortIndex":115,"researcher":26,"roles":841,"affiliations":842,"properties":848},"4755ec38-4344-4dc0-a5a3-5afcef6f72f5",[696],[843],{"id":26,"sortIndex":36,"affiliation":844,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":845,"slug":26,"properties":846,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":847},{"VI":799},{"title":849},{"VI":850},"S. Curinier",{"id":852,"sortIndex":162,"researcher":26,"roles":853,"affiliations":854,"properties":860},"444c2686-0290-4423-852c-e0810bccc815",[696],[855],{"id":26,"sortIndex":36,"affiliation":856,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":857,"slug":26,"properties":858,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":859},{"VI":799},{"title":861},{"VI":862},"D. Gallot",{"url":786,"publisher":864,"properties":872},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":865,"slug":662,"properties":866,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":869,"manageAffiliations":870,"indexDatabases":871,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":867,"title":868},{"VOID":665},{"EN":667},[],[],[],{"volume":873,"pages":875},{"VOID":874},"49",{"VOID":876},"1-11","2013-09-01",2013,{"id":880,"createTime":881,"updateTime":882,"relativeEntities":883,"slug":884,"properties":885,"entityType":688,"verifyStatus":25,"verifyTime":882,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":892,"fullTextUrl":26,"authors":893,"publicationType":747,"publisherRelationship":933,"citationCount":26,"citationInfo":26,"publishDate":947,"publishYear":948,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"efb0a041-615f-4e20-b346-1ea178210d32","2024-01-09T14:09:39.504+00:00","2025-02-23T17:47:43.208+00:00",[],"Embarazos-m%C3%BAltiples-estudio-anatomocl%C3%ADnico-y-tratamiento",{"references":886,"title":888,"doi":890},{"VOID":887},"Tandberg, 2010, Trends in incidence and mortality for triplets in Norway 1967-2006: the influence of assisted reproductive technologies, BJOG, 117, 667, 10.1111\u002Fj.1471-0528.2010.02530.x\nLuke, 2008, Maternal morbidity and infant death in twin vs triplet and quadruplet pregnancies, Am J Obstet Gynecol, 198, 10.1016\u002Fj.ajog.2007.10.785\nQuarello E, Ville Y. Syndrome transfuseur-transfusé : diagnostic et traitement. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-031-A-60, 2011.\nInstitut national d’études démographiques (INED). Accouchements multiples. www.ined.fr\u002Ffr\u002Ftout-savoir-population\u002Fchiffres\u002Ffrance\u002Fnaissance-fecondite\u002Faccouchements-multiples.\nSperling, 2007, Detection of chromosomal abnormalities, congenital abnormalities and transfusion syndrome in twins, Ultrasound Obstet Gynecol, 29, 517, 10.1002\u002Fuog.3918\nGlinianaia, 2008, Congenital anomalies in twins: a register-based study, Hum Reprod, 23, 1306, 10.1093\u002Fhumrep\u002Fden104\nGuilherme, 2009, Zygosity and chorionicity in triplet pregnancies: new data, Hum Reprod, 24, 100, 10.1093\u002Fhumrep\u002Fden364\nMachin, 1996, Zygosity and placental anatomy in 15 consecutive sets of spontaneously conceived triplets, Am J Med Genet, 61, 247, 10.1002\u002F(SICI)1096-8628(19960122)61:3\u003C247::AID-AJMG8>3.0.CO;2-R\nAgence de biomédecine. Le rapport médical et scientifique de l’Agence de la biomédecine 2015. Le rapport médical et scientifique de l’assistance médicale à la procréation et de la génétique humaines en France (tableau AMP3 : Inséminations, transferts d’embryons et accouchements multiples de 2011 à 2014). www.agence-biomedecine.fr.\nPison G. Près de la moitié des jumeaux naissent en Afrique. Population & Sociétés (INED). (n°360). Septembre 2000.\nPison G, Couvert N. La fréquence des accouchements gémellaires en France. La triple influence de la biologie, de la médecine et des comportements familiaux. In: Population, 59e année (n°6), 2004. p. 877-907.\nVan Mieghem, 2011, Fetal and maternal hemodynamics in pregnancy: new insights in the cardiovascular adaptation to uncomplicated pregnancy, twin-to-twin transfusion syndrome and congenital diaphragmatic hernia, Facts Views Vis Obgyn, 3, 205\nKametas, 2003, Maternal cardiac function in twin pregnancy, Obstet Gynecol, 102, 806\nKuleva, 2011, Maternal cardiac function in normal twin pregnancy: a longitudinal study, Ultrasound Obstet Gynecol, 38, 575, 10.1002\u002Fuog.8936\nGhi, 2015, Maternal cardiac evaluation during uncomplicated twin pregnancy with emphasis on the diastolic function, Am J Obstet Gynecol, 213, 10.1016\u002Fj.ajog.2015.05.003\nKrotz, 2002, Hypertensive disease in twin pregnancies: a review, Twin Res, 5, 8, 10.1375\u002Ftwin.5.1.8\nLučovnik, 2012, Risk factors for preeclampsia in twin pregnancies: a population-based matched case-control study, J Perinat Med, 40, 379, 10.1515\u002Fjpm-2011-0252\nFox, 2014, Risk factors for preeclampsia in twin pregnancies, Am J Perinatol, 31, 163\nUmadia, 2016, Preeclampsia in twin pregnancies, J Matern Fetal Neonatal Med, 29, 15, 10.1080\u002F14767058.2016.1234775\nCarter, 2015, The impact of chorionicity on maternal pregnancy outcomes, Am J Obstet Gynecol, 213, 390.e1-7, 10.1016\u002Fj.ajog.2015.05.027\nSparks, 2013, Does risk of preeclampsia differ by twin chorionicity?, J Matern Fetal Neonatal Med, 26, 1273, 10.3109\u002F14767058.2013.777701\nBartnik, 2016, Twin chorionicity and the risk of hypertensive disorders: gestational hypertension and pre-eclampsia, Twin Res Hum Genet, 19, 377, 10.1017\u002Fthg.2016.17\nCampbell, 1999, Preeclampsia in twin pregnancies: incidence and outcome, Hypertens Pregnancy, 18, 197, 10.3109\u002F10641959909016193\nSavvidou, 2001, Twin chorionicity and pre-eclampsia, Ultrasound Obstet Gynecol, 18, 228, 10.1046\u002Fj.0960-7692.2001.00470.x\nFoo, 2013, Characteristics of hypertensive disorders in twin versus singleton pregnancies, Pregnancy Hypertens, 3, 3, 10.1016\u002Fj.preghy.2012.05.005\nConnolly, 2016, Maternal clinical disease characteristics and maternal and neonatal outcomes in twin and singleton pregnancies with severe preeclampsia, Eur J Obstet Gynecol Reprod Biol, 201, 36, 10.1016\u002Fj.ejogrb.2015.11.031\nOsmundson, 2014, Maternal proteinuria in twin compared with singleton pregnancies, Obstet Gynecol, 124, 332, 10.1097\u002FAOG.0000000000000383\nLuo, 2006, Effect on neonatal outcomes in gestational hypertension in twin compared with singleton pregnancies, Obstet Gynecol, 108, 1138, 10.1097\u002F01.AOG.0000238335.61452.89\nSibai, 2000, Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, Am J Obstet Gynecol, 182, 938, 10.1016\u002FS0002-9378(00)70350-4\nFox, 2014, The relationship between preeclampsia and intrauterine growth restriction in twin pregnancies, Am J Obstet Gynecol, 211, 10.1016\u002Fj.ajog.2014.05.035\nFerrazzani, 2015, Is gestational hypertension beneficial in twin pregnancies?, Pregnancy Hypertens, 5, 171, 10.1016\u002Fj.preghy.2015.01.003\nHehir, 2016, Gestational hypertensive disease in twin pregnancy: influence on outcomes in a large national prospective cohort, Aust N Z J Obstet Gynaecol, 56, 466, 10.1111\u002Fajo.12483\nSparks, 2017, Hypertension in dichorionic twin gestations: how is birthweight affected?, J Matern Fetal Neonatal Med, 30, 380, 10.3109\u002F14767058.2016.1174209\nPalei, 2013, Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology, Acta Physiol, 208, 224, 10.1111\u002Fapha.12106\nBdolah, 2008, Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?, Am J Obstet Gynecol, 198, 10.1016\u002Fj.ajog.2007.10.783\nFaupel-Badger, 2015, Maternal circulating angiogenic factors in twin and singleton pregnancies, Am J Obstet Gynecol, 212, 10.1016\u002Fj.ajog.2014.11.035\nRana, 2012, Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia, Hypertension, 60, 451, 10.1161\u002FHYPERTENSIONAHA.112.195065\nDröge, 2015, Maternal serum sFlt-1\u002FPlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies, Ultrasound Obstet Gynecol, 45, 286, 10.1002\u002Fuog.14760\nLai, 2016, Outcomes of singleton and twin pregnancies complicated by pre-existing diabetes and gestational diabetes: a population-based study in Alberta, Canada, 2005-11, J Diabetes, 8, 45, 10.1111\u002F1753-0407.12255\nMorikawa, 2015, Prevalence of hyperglycaemia in singleton versus twin pregnancy, Diabetes Metab Res Rev, 31, 198, 10.1002\u002Fdmrr.2586\nMcGrath, 2017, Outcomes of twin pregnancies complicated by gestational diabetes: a meta-analysis of observational studies, J Perinatol, 37, 360, 10.1038\u002Fjp.2016.254\nTward, 2016, Does gestational diabetes affect fetal growth and pregnancy outcome in twin pregnancies?, Am J Obstet Gynecol, 214, 10.1016\u002Fj.ajog.2015.11.006\nPoulain, 2015, Outcome of twin pregnancies associated with glucose intolerance, Diabetes Metab, 41, 387, 10.1016\u002Fj.diabet.2014.12.005\nD’Antonio, 2013, Early fetal loss in monochorionic and dichorionic twin pregnancies: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort, Ultrasound Obstet Gynecol, 41, 632, 10.1002\u002Fuog.12363\nKristiansen, 2015, Perinatal outcome after first-trimester risk assessment in monochorionic and dichorionic twin pregnancies: a population-based register study, BJOG, 122, 1362, 10.1111\u002F1471-0528.13326\nMahony, 2011, Fetal death in twins, Acta Obstet Gynecol Scand, 90, 1274, 10.1111\u002Fj.1600-0412.2011.01239.x\nRusso, 2013, Stillbirths in singletons, dichorionic and monochorionic twins: a comparison of risks and causes, Eur J Obstet Gynecol Reprod Biol, 170, 131, 10.1016\u002Fj.ejogrb.2013.06.014\nSouthwest Thames Obstetric Research Collaborative (STORK)., 2012, Prospective risk of late stillbirth in monochorionic twins: a regional cohort study, Ultrasound Obstet Gynecol, 39, 500, 10.1002\u002Fuog.11110\nVasak, 2017, Lower perinatal mortality in preterm born twins than in singletons: a nationwide study from The Netherlands, Am J Obstet Gynecol, 216, 10.1016\u002Fj.ajog.2016.10.005\nPage, 2015, The risk of stillbirth and infant death by each additional week of expectant management in twin pregnancies, Am J Obstet Gynecol, 212\nCheong-See, 2016, Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis, Br Med J, 354, i4353, 10.1136\u002Fbmj.i4353\nOng, 2002, The creation of twin centile curves for size, BJOG, 109, 753, 10.1111\u002Fj.1471-0528.2002.01361.x\nGielen, 2008, Twin-specific intrauterine ‘growth’ charts based on cross-sectional birthweight data, Twin Res Hum Genet, 11, 224, 10.1375\u002Ftwin.11.2.224\nStirrup, 2015, Fetal growth reference ranges in twin pregnancy: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort, Ultrasound Obstet Gynecol, 45, 301, 10.1002\u002Fuog.14640\nOdibo, 2013, Customized growth charts for twin gestations to optimize identification of small-for-gestational age fetuses at risk of intrauterine fetal death, Ultrasound Obstet Gynecol, 41, 637, 10.1002\u002Fuog.12404\nGhi, 2017, Società Italiana di Ecografia Ostetrica e Ginecologica working group on fetal biometric charts. development of customized fetal growth charts in twins, Am J Obstet Gynecol, 216, 514\nBreathnach, 2012, Fetal growth disorders in twin gestations, Semin Perinatol, 36, 175, 10.1053\u002Fj.semperi.2012.02.002\nMiller, 2012, Discordant twins: diagnosis, evaluation and management, Am J Obstet Gynecol, 206, 10, 10.1016\u002Fj.ajog.2011.06.075\nHalling, 2016, Neuro-developmental outcome of a large cohort of growth discordant twins, Eur J Pediatr, 175, 381, 10.1007\u002Fs00431-015-2648-8\nRoss, 2012, Physical growth and cognitive abilities in concordant versus discordant birth weight twins at three years old, Early Hum Dev, 88, 753, 10.1016\u002Fj.earlhumdev.2012.04.001\nBlickstein, 2003, Intertwin birth weight discordance as a potential adaptive measure to promote gestational age, J Reprod Med, 48, 449\nHartley, 2002, Size-discordant twin pairs have higher perinatal mortality rates than nondiscordant pairs, Am J Obstet Gynecol, 187, 1173, 10.1067\u002Fmob.2002.126961\nHarper, 2013, Significance of growth discordance in appropriately grown twins, Am J Obstet Gynecol, 208, 10.1016\u002Fj.ajog.2013.01.044\nLopriore, 2012, Placental characteristics in growth-discordant monochorionic twins: a matched case-control study, Placenta, 33, 171, 10.1016\u002Fj.placenta.2011.12.004\nFraser, 1994, Birthweight discordance, intrauterine growth retardation and perinatal outcomes in twins, J Reprod Med, 39, 504\nHsieh, 1994, Growth discordancy, birthweight and neonatal adverse events in third trimester twin gestations, Gynecol Obstet Invest, 38, 36, 10.1159\u002F000292442\nTalbot, 1997, Is size discordancy an indication for delivery of preterm twins?, Am J Obstet Gynecol, 177, 1050, 10.1016\u002FS0002-9378(97)70013-9\nConde-Agudelo, 2010, Transvaginal sonographic cervical length for the prediction of spontaneous preterm birth in twin pregnancies: a systematic review and metaanalysis, Am J Obstet Gynecol, 203, 10.1016\u002Fj.ajog.2010.02.064\nFuchs, 2016, Multiple gestations and preterm birth, Semin Fetal Neonatal Med, 21, 113, 10.1016\u002Fj.siny.2015.12.010\nKazemier, 2014, Impact of obstetric history on the risk of spontaneous preterm birth in singleton and multiple pregnancies: a systematic review, BJOG, 121, 1197, 10.1111\u002F1471-0528.12896\nFox, 2015, Gestational age at cervical length and fetal fibronectin assessment and the incidence of spontaneous preterm birth in twins, J Ultrasound Med, 34, 977, 10.7863\u002Fultra.34.6.977\nKindinger, 2016, The effect of gestational age and cervical length measurements in the prediction of spontaneous preterm birth in twin pregnancies: an individual patient level meta-analysis, BJOG, 123, 877, 10.1111\u002F1471-0528.13575\nStock, 2010, Preterm and term labour in multiple pregnancies, Semin Fetal Neonatal Med, 15, 10.1016\u002Fj.siny.2010.06.006\nLewi, 2013, The vascular anastomoses in monochorionic twin pregnancies and their clinical consequences, Am J Obstet Gynecol, 208, 19, 10.1016\u002Fj.ajog.2012.09.025\nKhalil, 2016, ISUOG Practice Guidelines: role of ultrasound in twin pregnancy, Ultrasound Obstet Gynecol, 47, 247, 10.1002\u002Fuog.15821\nEssaoui M, Chalouhi GE, Stirnemann J, Salomon LJ, Ville Y. Physiopathologie du syndrome transfuseur-transfusé et principes de prise en charge. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-031-A-50, 2015.\nEmery, 2016, North American Fetal Therapy Network: intervention vs expectant management for stage I twin-twin transfusion syndrome, Am J Obstet Gynecol, 215, 10.1016\u002Fj.ajog.2016.04.024\nRoberts, 2008, Interventions for twin-twin transfusion syndrome: a Cochrane review, Ultrasound Obstet Gynecol, 31, 701, 10.1002\u002Fuog.5328\nRoberts, 2014, Interventions for the treatment of twin-twin transfusion syndrome, Cochrane Database Syst Rev\nLopriore, 2007, Twin anemia-polycythemia sequence in two monochorionic twin pairs without oligopolyhydramnios sequence, Placenta, 28, 47, 10.1016\u002Fj.placenta.2006.01.010\nSananès, 2015, Evaluation of the utility of in utero treatment of twin anemia-polycythemia sequence, Fetal Diagn Ther, 38, 170, 10.1159\u002F000380822\nOng, 2006, Prognosis for the co-twin following single-twin death: a systematic review, BJOG, 113, 992, 10.1111\u002Fj.1471-0528.2006.01027.x\nVayssière, 2011, Twin pregnancies: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF), Eur J Obstet Gynecol Reprod Biol, 156, 12, 10.1016\u002Fj.ejogrb.2010.12.045\nKilby, 2016, Management of monochorionic twin pregnancy, BJOG, 124, e1\nGil, 2015, Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis, Ultrasound Obstet Gynecol, 45, 249, 10.1002\u002Fuog.14791\nEvans, 1999, Selective termination for structural, chromosomal, and mendelian anomalies: international experience, Am J Obstet Gynecol, 181, 893, 10.1016\u002FS0002-9378(99)70321-2\nRossi, 2009, Umbilical cord occlusion for selective feticide in complicated monochorionic twins: a systematic review of literature, Am J Obstet Gynecol, 200, 123, 10.1016\u002Fj.ajog.2008.08.039\nRoman, 2010, Selective reduction in complicated monochorionic pregnancies: radiofrequency ablation vs bipolar cord coagulation, Ultrasound Obstet Gynecol, 36, 37, 10.1002\u002Fuog.7567\nLanna, 2012, Bipolar cord coagulation for selective feticide in complicated monochorionic twin pregnancies: 118 consecutive cases at a single center, Ultrasound Obstet Gynecol, 39, 407, 10.1002\u002Fuog.11073\nYinon, 2015, Selective reduction in complicated monochorionic twins: prediction of obstetric outcome and comparison of techniques, Ultrasound Obstet Gynecol, 46, 670, 10.1002\u002Fuog.14879\nCrowther, 2010, Hospitalisation and bed rest for multiple pregnancy, Cochrane Database Syst Rev\nYamasmit, 2012, Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy, Cochrane Database Syst Rev, 9, 10.1002\u002F14651858.CD004733.pub3\nSchuit, 2015, Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis, BJOG, 122, 27, 10.1111\u002F1471-0528.13032\nSenat, 2013, Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial, Am J Obstet Gynecol, 208\nRomero, 2017, Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data, Ultrasound Obstet Gynecol, 49, 303, 10.1002\u002Fuog.17397\nRebarber, 2014, Outcomes of emergency or physical examination-indicated cerclage in twin pregnancies compared to singleton pregnancies, Eur J Obstet Gynecol Reprod Biol, 173, 43, 10.1016\u002Fj.ejogrb.2013.11.016\nMiller, 2014, Outcomes after physical examination-indicated cerclage in twin gestations, Am J Obstet Gynecol, 211, 10.1016\u002Fj.ajog.2014.03.034\nRoman, 2016, Cerclage in twin pregnancy with dilated cervix between 16 to 24 weeks of gestation: retrospective cohort study, Am J Obstet Gynecol, 215, 10.1016\u002Fj.ajog.2016.01.172\nRoman, 2015, Efficacy of ultrasound-indicated cerclage in twin pregnancies, Am J Obstet Gynecol, 212, 10.1016\u002Fj.ajog.2015.01.031\nAllen, 2001, Management of monoamniotic twin pregnancies: a case series and systematic review of the litterature, BJOG, 108, 931\nPrefumo, 2015, The natural history of monoamniotic twin pregnancies: a case series and systematic review of the literature, Prenat Diagn, 35, 274, 10.1002\u002Fpd.4538\nHack, 2009, Perinatal outcome of monoamniotic twin pregnancies, Obstet Gynecol, 113, 353, 10.1097\u002FAOG.0b013e318195bd57\nDias, 2010, Cord entanglement and perinatal outcome in monoamniotic twin pregnancies, Ultrasound Obstet Gynecol, 35, 201, 10.1002\u002Fuog.7501\nRossi, 2013, Impact of cord entanglement on perinatal outcome of monoamniotic twins: a systematic review of the literature, Ultrasound Obstet Gynecol, 41, 131, 10.1002\u002Fuog.12345\nAnselem, 2015, Continued pregnancy and vaginal delivery after 32 weeks of gestation for monoamniotic twins, Eur J Obstet Gynecol Reprod Biol, 194, 194, 10.1016\u002Fj.ejogrb.2015.09.014\nMackenzie, 2002, The natural history of prenatally diagnosed conjoined twins, J Pediatr Surg, 37, 303, 10.1053\u002Fjpsu.2002.30830\nMorikawa, 2013, Clinical features and short term outcomes of triplet pregnancies in Japan, Int J Gynecol Obstet, 121, 86, 10.1016\u002Fj.ijgo.2012.10.022\nSkrablin, 2000, Maternal neonatal outcome in quadruplet and quintuplet versus triplet gestations, Eur J Obstet Gynecol Reprod Biol, 88, 147, 10.1016\u002FS0301-2115(99)00153-0\nChaveeva, 2013, Trichorionic and dichorionic triplet pregnancies at 10-14 weeks: outcome after embryo reduction compared to expectant management, Fetal Diagn Ther, 34, 199, 10.1159\u002F000356170",{"ES":889},"Embarazos múltiples: estudio anatomoclínico y tratamiento",{"VOID":891},"10.1016\u002Fs1283-081x(18)89342-0","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X18893420",[894,909,921],{"id":895,"sortIndex":114,"researcher":26,"roles":896,"affiliations":897,"properties":906},"ede3ac76-92ae-4df5-ba49-5dead1b725c8",[696],[898],{"id":26,"sortIndex":36,"affiliation":899,"properties":26},{"id":900,"createTime":901,"updateTime":901,"relativeEntities":902,"slug":26,"properties":903,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"84f9519c-edf3-4708-a354-2227b6e7389a","2024-01-09T14:09:39.554+00:00",[],{"title":904},{"VI":905},"Maternité Alix-de-Champagne, Hôpital Maison-Blanche, Université de Reims et CHU de Reims, 45, rue Cognacq-Jay, 51092 Reims cedex, France",{"title":907},{"VI":908},"J. Burette",{"id":910,"sortIndex":115,"researcher":26,"roles":911,"affiliations":912,"properties":918},"006a9a1f-458a-4b46-958c-22ea7e1d3bef",[696],[913],{"id":26,"sortIndex":36,"affiliation":914,"properties":26},{"id":900,"createTime":901,"updateTime":901,"relativeEntities":915,"slug":26,"properties":916,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":917},{"VI":905},{"title":919},{"VI":920},"S. Bonneau",{"id":922,"sortIndex":36,"researcher":26,"roles":923,"affiliations":924,"properties":930},"4211cd42-64bc-4339-a006-d24d126cbcb3",[696],[925],{"id":26,"sortIndex":36,"affiliation":926,"properties":26},{"id":900,"createTime":901,"updateTime":901,"relativeEntities":927,"slug":26,"properties":928,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":929},{"VI":905},{"title":931},{"VI":932},"R. Gabriel",{"url":892,"publisher":934,"properties":942},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":935,"slug":662,"properties":936,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":939,"manageAffiliations":940,"indexDatabases":941,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":937,"title":938},{"VOID":665},{"EN":667},[],[],[],{"volume":943,"pages":945},{"VOID":944},"54",{"VOID":946},"1-16","2018-06-01",2018,{"id":950,"createTime":951,"updateTime":951,"relativeEntities":952,"slug":26,"properties":953,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":960,"fullTextUrl":26,"authors":961,"publicationType":747,"publisherRelationship":977,"citationCount":26,"citationInfo":26,"publishDate":991,"publishYear":992,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"1ad1c2b9-52c9-43b7-bb8c-582146d3f99d","2024-02-11T20:38:54.987+00:00",[],{"references":954,"title":956,"doi":958},{"VOID":955},"Tijo, 1956, The chromosome number of man, Hereditas, 42, 1, 10.1111\u002Fj.1601-5223.1956.tb03010.x\nLejeune, 1959, Étude des chromosomes somatiques de neuf enfants mongoliens, CR Acad Sci Paris, 248, 1721\nBoué, 1976, Diagnostic prénatal des anomalies chromosomiques, Arch Fr Pediatr, 33, 653\nBoué, 1979, Diagnostic prénatal : résultat de 1532 ponctions amniotiques et étude prospective de 1023 cas, Nouv Presse Med, 8, 2949\nBoué, 1984, A colla borative study of the segregation of inherited chromosome structural rearrangements in 1356 prenatal diagnoses, Prenat Diagn, 4, 45, 10.1002\u002Fpd.1970040705\nGoossens, 1981, Antenatal diagnosis of sickle-cell anaemia by DNA analysis of amniotic fluid cells. A preliminary study in the French West-Indies, Nouv Presse Med, 10, 387\nGoossens, 1983, Prenatal diagnosis of sickle-cell anemia in the first trimester of pregnancy, N Engl J Med, 309, 831, 10.1056\u002FNEJM198310063091405\nDaffos, 1983, Fetal blood sampling via the umbilical cord using a needle guided by ultrasound, Report of 66 cases. Prenat Diagn, 3, 271, 10.1002\u002Fpd.1970030402\nAgence de la biomédecine. Rapport médical et scientifique; 2020.\nNicolaides, 2004, Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities, Am J Obstet Gynecol, 191, 45, 10.1016\u002Fj.ajog.2004.03.090\nMuller, 2014, Dépistage de la trisomie 21 par les marqueurs sériques maternels : justification des commentaires appliqués par les biologistes, J Gynecol Obstet Biol Reprod, 43, 671, 10.1016\u002Fj.jgyn.2014.05.012\nHaute Autorité de santé. Recommandation : dépistage et diagnostic prénatals de la trisomie 21. Méthode de réalisation de l’outil d’information à destination des femmes enceintes ou des couples; 2018.\nHaute Autorité de santé. « Dépistage des trisomies »; 2019.\nLo, 2007, Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection, Nat Med, 13, 218, 10.1038\u002Fnm1530\nLo, 1997, Presence of fetal DNA in maternal plasma and serum, Lancet, 350, 485, 10.1016\u002FS0140-6736(97)02174-0\nHill, 2011, Non-invasive prenatal determination of fetal sex: translating research into clinical practice, Clin Genet, 80, 68, 10.1111\u002Fj.1399-0004.2010.01533.x\nLo, 1998, Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma, N Engl J Med, 339, 1734, 10.1056\u002FNEJM199812103392402\nTong, 2006, Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations, Clin Chem, 52, 2194, 10.1373\u002Fclinchem.2006.076851\nChiu, 2008, Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma, Proc Natl Acad Sci, 105, 20458, 10.1073\u002Fpnas.0810641105\nFan, 2008, Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood, Proc Natl Acad Sci, 105, 16266, 10.1073\u002Fpnas.0808319105\nPalomaki, 2011, DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study, Genet Med, 13, 913, 10.1097\u002FGIM.0b013e3182368a0e\nPalomaki, 2012, DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collab orative study, Genet Med, 14, 296, 10.1038\u002Fgim.2011.73\nChen, 2011, Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing, Plos One, 6\nLun, 2011, Noninvasive prenatal diagnosis of a case of Down syndrome due to robertsonian translocation by massively parallel sequencing of maternal plasma DNA, Clin Chem, 57, 917, 10.1373\u002Fclinchem.2011.161844\nCanick, 2012, DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations, Prenat Diagn, 32, 730, 10.1002\u002Fpd.3892\nHaute Autorité de santé. Recommandation : place des tests ADN libre circulant dans le sang maternel dans le dépistage de la trisomie 21 foetale; recommandation en santé publique; 2017.\nWang, 2015, Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases, Genet Med, 17, 234, 10.1038\u002Fgim.2014.92\nPoon, 2016, IONA test for first-trimester detection of trisomies 21, 18 and 13, Ultrasound Obstet Gynecol, 47, 184, 10.1002\u002Fuog.15749\nAssociation des cytogénéticiens de langue française. Recommandations sur la conduite à tenir devant l’identification d’anomalies chromosomiques foetales autres que les trisomies 13, 18 et 21 par l’étude de l’ADN libre circulant (ADNlc); 2020.\nLindquist, 2018, Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing, Ultrasound Obstet Gynecol, 51, 487, 10.1002\u002Fuog.18979\nFiorentino, 2017, The clinical utility of genome-wide non invasive prenatal screening, Prenat Diagn, 37, 593, 10.1002\u002Fpd.5053\nvan der Meij, 2019, TRIDENT-2: National implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands, Am J Hum Genet, 105, 1091, 10.1016\u002Fj.ajhg.2019.10.005\nEhrich, 2017, Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases, Genet Med, 19, 1332, 10.1038\u002Fgim.2017.56\nGross, 2016, Clinical experience with single-nucleotide polymorphism-based noninvasive prenatal screening for 22q11.2 deletion syndrome, Ultrasound Obstet Gynecol, 47, 177, 10.1002\u002Fuog.15754\nHelgeson, 2015, Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing, Prenat Diagn, 35, 999, 10.1002\u002Fpd.4640\nValderramos, 2016, screening in clinical practice: abnormal autosomal aneuploidy and microdeletion results, Am J Obstet Gynecol, 215, 626, 10.1016\u002Fj.ajog.2016.06.039\nPei, 2020, Efficiency of noninvasive prenatal testing for the detection of fetal microdeletions and microduplications in autosomal chromosomes, Mol Genet Genomic Med, 8, 10.1002\u002Fmgg3.1339\nWu, 2020, Applying high-throughput sequencing to identify and evaluate foetal chromosomal deletion and duplication, J Cell Mol Med, 24, 9936, 10.1111\u002Fjcmm.15593\nRecommandations pour le dépistage des anomalies chromosomiques fœtales par l’étude de l’ADN libre circulant (ADNlc) ACLF V4. 2019.\nAssociation des cytogénéticiens de langue française. Arbre décisionnel : caryotype sur villosités choriales.\nCacheux, 1994, Evaluation of X, Y, 18, and 13\u002F21 alpha satellite DNA probes for interphase cytogenetic analysis of uncultured amniocytes by fluorescence in situ hybridization, Prenat Diagn, 14, 79, 10.1002\u002Fpd.1970140202\nMcGowan-Jordan J, Hastings Ros J., Moore S. In: ISCN: An international system for human cytogenetic nomenclature. Recommendations of the International Standing Committee on Human. Published in collaboration with Cytogenetic and Genome Research; 2020.\nShaffer, 2011, The development of a rapid assay for prenatal testing of common aneuploidies and microdeletion syndromes, Prenat Diagn, 31, 778, 10.1002\u002Fpd.2766\nVialard, 2012, Prenatal BACs-on-Beads: the prospective experience of five prenatal diagnosis laboratories, Prenat Diagn, 32, 329, 10.1002\u002Fpd.2934\nDunbar, 2006, Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection, Clin Chim Acta, 363, 71, 10.1016\u002Fj.cccn.2005.06.023\nDe la Chapelle, 1981, A deletion in chromosome 22 can cause DiGeorge syndrome, Hum Genet, 57, 253, 10.1007\u002FBF00278938\nDupont, 2015, Prenatal diagnosis of 24 cases of microduplication 22q11.2: an investigation of phenotype-genotype correlations, Prenat Diagn, 35, 35, 10.1002\u002Fpd.4478\nGrati, 2013, Application of a new molecular technique for the genetic evaluation of products of conception, Prenat Diagn, 33, 32, 10.1002\u002Fpd.4004\nAchropuce. Guide de bonnes pratiques ACPA en diagnostic prénatal 2020 (v2.2).\nAssociation des cytogénéticiens de langue française. Guide de bonnes pratiques de cytogénétique (version 4); 2020.\nMcKinlay Gardner, 2018\nBoué, 1973, Outcome of pregnancies following a spontaneous abortion with chromosomal anomalies, Am J Obstet Gynecol, 161, 806, 10.1016\u002F0002-9378(73)91013-2\nPlachot, 1989, Chromosome analysis of spontaneous abortions after IVF. A European survey, Hum Reprod, 4, 425, 10.1093\u002Foxfordjournals.humrep.a136921\nTurleau, 2004, 71\nEdwards, 1960, A new trisomic syndrome, Lancet, 1, 787, 10.1016\u002FS0140-6736(60)90675-9\nPatau, 1960, Multiple congenital anomaly caused by an extra autosome, Lancet, 1, 790, 10.1016\u002FS0140-6736(60)90676-0\nPellestor, 1991, Frequency and distribution of aneuploidy in human female gametes, Hum Genet, 86, 283, 10.1007\u002FBF00202410\nHassold, 1993, Trisomy in human: incidence, origin and etiology, Curr Opin Genet Dev, 3, 398, 10.1016\u002F0959-437X(93)90111-2\nAngell, 1994, First meiotic division abnormalities in human aneuploidy in human ovocytes: mechanism of trisomy formation, Cytogenet Cell Genet, 65, 194, 10.1159\u002F000133631\nDe Grouchy, 1984\nSiffroi, 1997, Assisted reproductive technology and complex chromosomal rearrangements: the limits of ICSI, Mol Hum Reprod, 3, 847, 10.1093\u002Fmolehr\u002F3.10.847\nKeren, 2008, Nouveaux outils diagnostiques du retard mental, Mt Pediatr, 11, 230\nUnk, 2016, American College of Obstetricians and Gynecologists; Committee on Practice Bulletins–Obstetrics; Committee on Genetics; Society for Maternal–Fetal, Medicine, Practice Bulletin, No, 162, Obstet Gynecol, 127, e108\nAudibert, 2017, No. 348-Joint SOGC-CCMG Guideline: Update on prenatal screening for fetal aneuploidy, fetal anomalies, and adverse pregnancy outcomes, J Obstet Gynaecol Canada, 39, 805, 10.1016\u002Fj.jogc.2017.01.032\nDuncan, 2011, Use of array genomic hybridization technology in prenatal diagnosis in Canada, J Obstet Gynaecol Can, 33, 1256, 10.1016\u002FS1701-2163(16)35112-X\nArmour, 2018, Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada, J Med Genet, 55, 215, 10.1136\u002Fjmedgenet-2017-105013\nSteemers, 2006, Whole-genome genotyping with the single-base extension assay, Nat Methods, 3, 31, 10.1038\u002Fnmeth842\nMalan, 2012, Diagnosis of chromosomal abnormalities by array CGH in constitutional pathology: the end of the first-line karyotype. Diagnostic des anomalies chromosomiques par CGH array en pathologie constitutionnelle : la fin du caryotype en première intention, Arch Pediatr, 19, 437, 10.1016\u002Fj.arcped.2012.01.004\nCooper, 2011, A copy number variation morbidity map of developmental delay, Nat Genet, 43, 838, 10.1038\u002Fng.909\nConrad, 2010, Origins and functional impact of copy number variation in the human genome, Nature, 464, 704, 10.1038\u002Fnature08516\nLee, 2007, Copy number variations and clinical cytogenetic diagnosis of constitutional disorders, Nat Genet, 39, S48, 10.1038\u002Fng2092\nBreman, 2012, Prenatal chromosomal microarray analysis in a diagnostic laboratory: experience with >1000 cases and review of the literature, Prenat Diagn, 32, 351, 10.1002\u002Fpd.3861\nShaffer, 2012, Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies, Prenat Diagn, 32, 976, 10.1002\u002Fpd.3945\nHillman, 2013, Use of prenatal chromosomal microarray: Prospective cohort study and systematic review and meta-analysis, Ultrasound Obstet Gynecol, 41, 610, 10.1002\u002Fuog.12464\nDe Wit, 2014, Additional value of prenatal genomic array testing in fetuses with isolated structural ultrasound abnormalities and a normal karyotype: A systematic review of the literature, Ultrasound Obstet Gynecol, 43, 139, 10.1002\u002Fuog.12575\nMalan, 2016, A French approach to test fetuses with ultrasound abnormalities using a customized microarray as first-tier genetic test, Cytogenet Genome Res, 147, 103\nWapner, 2012, Chromosomal microarray versus karyotyping for prenatal diagnosis, N Engl J Med, 367, 2175, 10.1056\u002FNEJMoa1203382\nPapoulidis, 2015, Routine use of array comparative genomic hybridization (aCGH) as standard approach for prenatal diagnosis of chromosomal abnormalities. Clinical experience of 1763 prenatal cases, Prenat Diagn, 35, 1269, 10.1002\u002Fpd.4685\nSrebniak, 2016, array testing in 1000 fetuses with ultrasound anomalies: Causative, unexpected and susceptibility CNVs, Eur J Hum Genet, 24, 645, 10.1038\u002Fejhg.2015.193\nParchem, 2018, Utility of chromosomal microarray in anomalous fetuses, Prenat Diagn, 38, 140, 10.1002\u002Fpd.5202\nRachid, 2021, Six years of molecular cytogenetic in prenatal diagnosis: benefits, lessons and perspectives, Prenatal diagnosis\nPangalos, 2016, First applications of a targeted exome sequencing approach in fetuses with ultrasound abnormalities reveals an important fraction of cases with associated gene defects, Peer J, 4, 10.7717\u002Fpeerj.1955\nNg, 2008, Genetic variation in an individual human exome, PLoS Genet, 4, 10.1371\u002Fjournal.pgen.1000160\nStenson, 2009, The Human Gene Mutation Database: providing a comprehensive central mutation database for molecular diagnostics and personalized genomics, Hum Genomics, 4, 69, 10.1186\u002F1479-7364-4-2-69\nNg, 2009, Targeted capture and massively parallel sequencing of 12 human exomes, Nature, 461, 272, 10.1038\u002Fnature08250\nMcMullan DJ, Eberhardt R, Rinck G, et al. Exome sequencing of 406 parental\u002Ffetal trios with structural abnormalities revealed by ultrasound in the UK prenatal assessment of genomes and exomes (PAGE) Project. European Society of Human Genetics Copenhagen (Danemark); 2017.\nChandler, 2018, Rapid prenatal diagnosis using targeted exome sequencing: a cohort study to assess feasibility and potential impact on prenatal counseling and pregnancy management, Genet Med, 20, 1430, 10.1038\u002Fgim.2018.30\nAarabi, 2018, Importance of complete phenotyping in prenatal whole exome sequencing, Hum Genet, 137, 175, 10.1007\u002Fs00439-017-1860-1\nYadava, 2017, 125: Whole exome sequencing (WES) in prenatal diagnosis for carefully selected cases, Am J Obstet Gynecol, 216, S87, 10.1016\u002Fj.ajog.2016.11.029\nVora, 2017, Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges, Genet Med, 10.1038\u002Fgim.2017.33\nCarss, 2014, Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound, Hum Mol Genet, 23, 3269, 10.1093\u002Fhmg\u002Fddu038\nDaum, 2019, Collaborating authors. Fetal exome sequencing: yield and limitations in a single tertiary center, Ultrasound Obstet Gynecol, 53, 80, 10.1002\u002Fuog.19168\nYates, 2017, Whole-exome sequencing on deceased fetuses with ultrasound anomalies: expanding our knowledge of genetic disease during fetal development, Genet Med, 19, 1171, 10.1038\u002Fgim.2017.31\nDrury, 2016, Prenatal diagnosis of sonographic abnormalities using rapid whole exome sequencing, Prenat Diagn, 36, 51\nLeung, 2018, Identifying the genetic causes for prenatally diagnosed structural congenital anomalies (SCAs) by whole-exome sequencing (WES), BMC Med Genomics, 11, 93, 10.1186\u002Fs12920-018-0409-z\nYang, 2014, Molecular findings among patients referred for clinical whole-exome sequencing, JAMA, 312, 1870, 10.1001\u002Fjama.2014.14601\nWalkiewicz M, Braxton A, Liu P, Xia PF, Bi W, Xiao R, et al. The utility of whole exome sequencing in prenatal diagnosis; Presented at the American Society of Human Genetics Annual Meeting: Vancouver; 2016.\nBarnett CP, Byrne A, Moore L, Khong Y, Manton N, Lipsett J, et al. The genomic autopsy: using whole exome and whole genome sequencing to solve complex fetal and neonatal presentations; Presented at the American Society of Human Genetics Annual Meeting: Vancouver; 2016.\nRyan E, Friedman B, Haskins A, Barbar R, Nelson Z, Al-Musafri F, et al. Whole exome sequencing in 129 fetuses with abnormal ultrasound findings; Presented at ACMG Annual Clinical Genetics Meeting; Phoenix, Arizona ; 2017.\nWapner, 2017, Whole exome sequencing in the evaluation of fetal structural anomalies: a prospective study of sequential patients, Am J Obstet Gynecol, 216, S5, 10.1016\u002Fj.ajog.2016.11.009\nLord, 2019, Prenatal Assessment of Genomes and Exomes Consortium. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study, Lancet, 393, 747, 10.1016\u002FS0140-6736(18)31940-8\nSá, 2018, Broad multi-gene panel or whole exome sequencing in malformed fetuses reveals eight definitive and one likely diagnoses in fifteen studied fetus, in prenatal setting, Eur J Hum Genet, 26, 129\nRichards, 2015, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, 17, 405, 10.1038\u002Fgim.2015.30\nHarris, 2018, Ethical and counseling challenges in prenatal exome sequencing, Prenat Diagn, 38, 897, 10.1002\u002Fpd.5353\nHeide, 2020, Prenatal exome sequencing in 65 fetuses with abnormality of the corpus callosum: contribution to further diagnostic delineation, Genet Med, 22, 1887, 10.1038\u002Fs41436-020-0872-8\nConseil génétique. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-019-A-10].\nAlamillo, 2015, Exome sequencing positively identified relevant alterations in more than half of cases with an indication of prenatal ultrasound anomalies, Prenat Diagn, 35, 1073, 10.1002\u002Fpd.4648",{"ES":957},"Citogenética prenatal",{"VOID":959},"10.1016\u002Fs1283-081x(22)47073-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X22470731",[962],{"id":963,"sortIndex":36,"researcher":26,"roles":964,"affiliations":965,"properties":974},"1ed569b5-be6c-4e55-89af-c49d6c802f3c",[696],[966],{"id":26,"sortIndex":36,"affiliation":967,"properties":26},{"id":968,"createTime":969,"updateTime":969,"relativeEntities":970,"slug":26,"properties":971,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4f06ffb7-7bf3-4e94-9265-6f6a982ecfa4","2024-02-11T20:38:55.006+00:00",[],{"title":972},{"VI":973},"Unité fonctionnelle de cytogénétique, Département de génétique, Hôpital Robert-Debré, AP–HP, 48, boulevard Serrurier, 75019 Paris, France",{"title":975},{"VI":976},"C. Dupont",{"url":960,"publisher":978,"properties":986},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":979,"slug":662,"properties":980,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":983,"manageAffiliations":984,"indexDatabases":985,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":981,"title":982},{"VOID":665},{"EN":667},[],[],[],{"volume":987,"pages":989},{"VOID":988},"58",{"VOID":990},"1-28","2022-12-01",2022,{"id":994,"createTime":995,"updateTime":996,"relativeEntities":997,"slug":998,"properties":999,"entityType":688,"verifyStatus":25,"verifyTime":996,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":1006,"fullTextUrl":26,"authors":1007,"publicationType":747,"publisherRelationship":1134,"citationCount":26,"citationInfo":26,"publishDate":1148,"publishYear":1149,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"685c10b1-ef75-4288-a275-04c7b3e0894d","2024-02-14T04:35:30.152+00:00","2025-01-26T10:48:59.293+00:00",[],"Laparoscopia-y-cirug%C3%ADa-laparosc%C3%B3pica-principios-generales-e-instrumental",{"references":1000,"title":1002,"doi":1004},{"VOID":1001},"Palmer, 1948, La cœlioscopie, Bruxells Med., 28, 305\nBruhat, 1979, Essai d'un traitement per cœlioscopique de la grossesse extra-utérine : à propos de 26 observations, Rev. Fr. Gynecol. Obstet., 72, 667\nReich, 1989, Laparoscopic hysterectomy, J. Gynecol. Surg., 5, 213, 10.1089\u002Fgyn.1989.5.213\nwww.websurg.com.\nBruhat, 1991\nHolzer, 2006, Laparoscopic versus open myomectomy: a double-blind study to evaluate postoperative pain, Anesth. Analg., 102, 1480, 10.1213\u002F01.ane.0000204321.85599.0d\nGarry, 2006, Laparoscopic surgery, Best Pract. Res. Clin. Obstet. Gynecol., 20, 89, 10.1016\u002Fj.bpobgyn.2005.10.003\nGarry, 1997, Complications of laparoscopic entry, Gynecol. Endosc., 6, 319, 10.1111\u002Fj.1365-2508.1997.151-gy0558.x\nQuerleu, 1993, Complications of gynaecological laparoscopic surgery: a French collaborative study, Gynecol. Endosc., 2, 3\nChapron, 1998, Surgical complications of diagnostic and operative gynaecological laparoscopy. A series of 29 966 cases, Hum. Reprod., 13, 867, 10.1093\u002Fhumrep\u002F13.4.867\nMenes, 2000, Laparoscopy: searching for the proper insufflation gas, Surg. Endosc., 14, 1050, 10.1007\u002Fs004640000216\nGutt, 2004, Circulatory and respiratory complications of carbon dioxide insufflation, Dig. Surg., 21, 95, 10.1159\u002F000077038\nElkelani, 2004, Effect of adding more than 3% oxygen to carbon dioxide pneumoperitoneum on adhesion formation in a laparoscopic mouse model, Fertil. Steril., 82, 1616, 10.1016\u002Fj.fertnstert.2004.07.933\nLarsen, 2004, Randomized clinical trial of the effect of pneumoperitoneum on cardiac function and haemodynamics during laparoscopic cholecystectomy, Br. J. Surg., 91, 848, 10.1002\u002Fbjs.4573\nAlijani, 2004, Abdominal wall lift versus positive-pressure capnoperitoneum for laparoscopic cholecystectomy: randomized controlled trial, Ann. Surg., 239, 388, 10.1097\u002F01.sla.0000114226.31773.e3\nNeudecker, 2002, The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery, Surg. Endosc., 16, 1121, 10.1007\u002Fs00464-001-9166-7\nMalik, 2000, Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid, Surg. Endosc., 14, 452, 10.1007\u002Fs004640000160\nLöning, 2004, Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX, Cancer, 100, 1650, 10.1002\u002Fcncr.20155\nBuchweitz, 2006, Detection of peritoneal endometriotic lesions by autofluorescence laparoscopy, Am. J. Obstet. Gynecol., 195, 949, 10.1016\u002Fj.ajog.2006.02.044\nKadar, 1993, Incisional hernias after major laparoscopic gynecologic procedures, Am. J. Obstet. Gynecol., 168, 1493, 10.1016\u002FS0002-9378(11)90787-X\nSinghvi, 2002, Assessment of the physical properties of endoscopic retrieval systems, Br. J. Surg., 89, 1183, 10.1046\u002Fj.1365-2168.2002.02192.x\nKöchli, 2000, Endobag extractor to remove masses during laparoscopy, Obstet. Gynecol., 95, 304\nHarold, 2003, Comparison of ultrasonic energy, bipolar thermal energy, and vascular clips for the hemostasis of small-, medium-, and large-sized arteries, Surg. Endosc., 17, 1228, 10.1007\u002Fs00464-002-8833-7\nDiamantis, 2006, Comparison of monopolar electrocoagulation, bipolar electrocoagulation, ultracision, and ligasure, Surg. Today, 36, 908, 10.1007\u002Fs00595-006-3254-1\nEmam, 2003, How safe is high-power ultrasonic dissection?, Ann. Surg., 237, 186, 10.1097\u002F01.SLA.0000048454.11276.62\nHensman, 1998, Chemical composition of smoke produced by high-frequency electrosurgery in a closed gaseous environment: an in-vitro study, Surg. Endosc., 12, 1017, 10.1007\u002Fs004649900771\n2006, Control and prevention of peritoneal adhesions in gynecologic surgery, Fertil. Steril., 86, S1, 10.1016\u002Fj.fertnstert.2006.07.1483\nAit Menguellet, 2007, Interest in agents for adhesion prevention after gynecologic surgery, Gynecol. Obstet. Fertil., 35, 290, 10.1016\u002Fj.gyobfe.2007.02.011\nBrown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, Dizerega GS; on behalf of the Adept Adhesion Reduction Study Group. Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomized, controlled study. Fertil. Steril. 2007; (Mar23;[Epub ahead of print]).",{"ES":1003},"Laparoscopia y cirugía laparoscópica: principios generales e instrumental",{"VOID":1005},"10.1016\u002Fs1283-081x(08)70808-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X08708087",[1008,1023,1035,1047,1059,1074,1086,1098,1110,1122],{"id":1009,"sortIndex":52,"researcher":26,"roles":1010,"affiliations":1011,"properties":1020},"c8c8b4c6-cad9-47b1-88b4-2fa9709cd311",[696],[1012],{"id":26,"sortIndex":36,"affiliation":1013,"properties":26},{"id":1014,"createTime":1015,"updateTime":1015,"relativeEntities":1016,"slug":26,"properties":1017,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"85222ac4-6572-4fda-bf7c-ff8b8443aea4","2024-02-14T04:35:30.184+00:00",[],{"title":1018},{"VI":1019},"Centre hospitalier universitaire de Clermont-Ferrand, Polyclinique de l'Hôtel-Dieu, service de gynécologie obstétrique et médecine de la reproduction, boulevard Léon-Malfreyt, 63000 Clermont-Ferrand, France",{"title":1021},{"VI":1022},"M. Canis",{"id":1024,"sortIndex":162,"researcher":26,"roles":1025,"affiliations":1026,"properties":1032},"a58dd99f-be9e-4f4c-be9a-25dc0e5d3625",[696],[1027],{"id":26,"sortIndex":36,"affiliation":1028,"properties":26},{"id":1014,"createTime":1015,"updateTime":1015,"relativeEntities":1029,"slug":26,"properties":1030,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1031},{"VI":1019},{"title":1033},{"VI":1034},"B. Rabischong",{"id":1036,"sortIndex":115,"researcher":26,"roles":1037,"affiliations":1038,"properties":1044},"87b8574f-629e-448c-8dd5-2c74efe52dd4",[696],[1039],{"id":26,"sortIndex":36,"affiliation":1040,"properties":26},{"id":1014,"createTime":1015,"updateTime":1015,"relativeEntities":1041,"slug":26,"properties":1042,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1043},{"VI":1019},{"title":1045},{"VI":1046},"L. Velemir",{"id":1048,"sortIndex":158,"researcher":26,"roles":1049,"affiliations":1050,"properties":1056},"aa307ae0-1c39-41bf-9b5d-d85b078d85f5",[696],[1051],{"id":26,"sortIndex":36,"affiliation":1052,"properties":26},{"id":1014,"createTime":1015,"updateTime":1015,"relativeEntities":1053,"slug":26,"properties":1054,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1055},{"VI":1019},{"title":1057},{"VI":1058},"J.-L. Pouly",{"id":1060,"sortIndex":114,"researcher":26,"roles":1061,"affiliations":1062,"properties":1071},"f9e4efa3-0037-48b4-ac7f-412129e460e9",[696],[1063],{"id":26,"sortIndex":36,"affiliation":1064,"properties":26},{"id":1065,"createTime":1066,"updateTime":1066,"relativeEntities":1067,"slug":26,"properties":1068,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b293de01-17b5-4cbf-ba79-716d1d09c39d","2024-02-14T04:35:30.198+00:00",[],{"title":1069},{"VI":1070},"Centre hospitalier universitaire de Strasbourg, service de gynécologie-obstétrique, 1, place de l'Hôpital, 67000 Strasbourg cedex, France",{"title":1072},{"VI":1073},"A. Wattiez",{"id":1075,"sortIndex":50,"researcher":26,"roles":1076,"affiliations":1077,"properties":1083},"59add75c-c97b-4abc-abff-ded75ae3ae12",[696],[1078],{"id":26,"sortIndex":36,"affiliation":1079,"properties":26},{"id":1014,"createTime":1015,"updateTime":1015,"relativeEntities":1080,"slug":26,"properties":1081,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1082},{"VI":1019},{"title":1084},{"VI":1085},"G. Mage",{"id":1087,"sortIndex":111,"researcher":26,"roles":1088,"affiliations":1089,"properties":1095},"f8509d99-5fd4-480b-9475-73f76ed302c4",[696],[1090],{"id":26,"sortIndex":36,"affiliation":1091,"properties":26},{"id":1014,"createTime":1015,"updateTime":1015,"relativeEntities":1092,"slug":26,"properties":1093,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1094},{"VI":1019},{"title":1096},{"VI":1097},"F. Bolandard",{"id":1099,"sortIndex":36,"researcher":26,"roles":1100,"affiliations":1101,"properties":1107},"146c4216-24f6-4d94-8f77-0d3dc19e95ff",[696],[1102],{"id":26,"sortIndex":36,"affiliation":1103,"properties":26},{"id":1014,"createTime":1015,"updateTime":1015,"relativeEntities":1104,"slug":26,"properties":1105,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1106},{"VI":1019},{"title":1108},{"VI":1109},"R. Botchorishvili",{"id":1111,"sortIndex":59,"researcher":26,"roles":1112,"affiliations":1113,"properties":1119},"f1fab820-877b-401f-b071-e34df3023ec3",[696],[1114],{"id":26,"sortIndex":36,"affiliation":1115,"properties":26},{"id":1014,"createTime":1015,"updateTime":1015,"relativeEntities":1116,"slug":26,"properties":1117,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1118},{"VI":1019},{"title":1120},{"VI":1121},"X. Tran",{"id":1123,"sortIndex":135,"researcher":26,"roles":1124,"affiliations":1125,"properties":1131},"e93b2b92-376f-4527-b159-2edb6a808f2a",[696],[1126],{"id":26,"sortIndex":36,"affiliation":1127,"properties":26},{"id":1014,"createTime":1015,"updateTime":1015,"relativeEntities":1128,"slug":26,"properties":1129,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1130},{"VI":1019},{"title":1132},{"VI":1133},"K. Jardon",{"url":1006,"publisher":1135,"properties":1143},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1136,"slug":662,"properties":1137,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1140,"manageAffiliations":1141,"indexDatabases":1142,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1138,"title":1139},{"VOID":665},{"EN":667},[],[],[],{"volume":1144,"pages":1146},{"VOID":1145},"44",{"VOID":1147},"1-15","2008-01-01",2008,{"id":1151,"createTime":1152,"updateTime":1153,"relativeEntities":1154,"slug":1155,"properties":1156,"entityType":688,"verifyStatus":25,"verifyTime":1163,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1164,"fullTextUrl":26,"authors":1165,"publicationType":747,"publisherRelationship":1193,"citationCount":26,"citationInfo":26,"publishDate":1206,"publishYear":1207,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"38efd8f4-8f94-4a9a-aab4-98037fde0cd2","2024-01-26T07:49:12.003+00:00","2025-02-09T14:37:55.955+00:00",[],"Recidivas-locorregionales-del-c%C3%A1ncer-de-mama",{"references":1157,"title":1159,"doi":1161},{"VOID":1158},"Site de l’institut national du cancer ; (http :\u002F\u002Flesdonnees.e-cancer.fr).\nAndry, 1989, Locoregional recurrences after 649 modified radical mastectomies : incidence and significance, Eur J Surg Oncol, 15, 476\nArriagada, 2002, Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer, Ann Oncol, 13, 1404, 10.1093\u002Fannonc\u002Fmdf227\nSchmoor, 2000, Role of isolated locoregional recurrence of breast cancer : results of four prospective studies, J Clin Oncol, 18, 1696, 10.1200\u002FJCO.2000.18.8.1696\nClemons, 2001, Locoregionally recurrent breast cancer : incidence, risk factors and survival, Cancer Treat Rev, 27, 67, 10.1053\u002Fctrv.2000.0204\nAnderson, 2009, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer, J Clin Oncol, 27, 2466, 10.1200\u002FJCO.2008.19.8424\nWapnir, 2006, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials, J Clin Oncol, 24, 2028, 10.1200\u002FJCO.2005.04.3273\nFortin, 1999, Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy, J Clin Oncol, 17, 101, 10.1200\u002FJCO.1999.17.1.101\nTaghian, 2004, J Clin Oncol, 22, 4247, 10.1200\u002FJCO.2004.01.042\nFisher, 1991, Significance of ipsilateral breast tumour recurrence after lumpectomy, Lancet, 338, 327, 10.1016\u002F0140-6736(91)90475-5\nFisher, 1992, Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation : pathological findings from NSABP protocol B-06, Semin Surg Oncol, 8, 161\nVeronesi, 1995, Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events, J Natl Cancer Inst, 87, 19, 10.1093\u002Fjnci\u002F87.1.19\nFisher, 2002, Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer, N Engl J Med, 347, 1233, 10.1056\u002FNEJMoa022152\nLe, 2002, Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma, Cancer, 94, 2813, 10.1002\u002Fcncr.10572\nGalper, 2005, Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer, Int J Radiat Oncol Biol Phys, 61, 348, 10.1016\u002Fj.ijrobp.2004.06.011\nSalvadori, 1999, Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery, Br J Surg, 86, 84, 10.1046\u002Fj.1365-2168.1999.00961.x\nClarke, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet, 366, 2087, 10.1016\u002FS0140-6736(05)67887-7\nVeronesi, 2002, Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer, N Engl J Med, 347, 1227, 10.1056\u002FNEJMoa020989\nJacobson, 1995, Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer, N Engl J Med, 332, 907, 10.1056\u002FNEJM199504063321402\nvan Dongen, 2000, Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial, J Natl Cancer Inst, 92, 1143, 10.1093\u002Fjnci\u002F92.14.1143\nSarrazin, 1989, Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer, Radiother Oncol, 14, 177, 10.1016\u002F0167-8140(89)90165-5\nBlichert-Toft, 1992, Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis, J Natl Cancer Inst Monogr, 19\nHuang, 2002, Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences, Cancer, 95, 2059, 10.1002\u002Fcncr.10952\nKomoike, 2005, Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors, Breast Cancer, 12, 104, 10.2325\u002Fjbcs.12.104\nYoshida, 2010, True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment, Breast J, 16, 127, 10.1111\u002Fj.1524-4741.2009.00884.x\nPanet-Raymond, 2011, True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy, Int J Radiat Oncol Biol Phys, 81, 409, 10.1016\u002Fj.ijrobp.2010.05.063\nYi, 2011, Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning, Ann Surg, 253, 572, 10.1097\u002FSLA.0b013e318208fc2a\nBollet, 2008, High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers, J Natl Cancer Inst, 100, 48, 10.1093\u002Fjnci\u002Fdjm266\nVicini, 2007, The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy, Cancer, 109, 1264, 10.1002\u002Fcncr.22529\nSmith, 2000, True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management, Int J Radiat Oncol Biol Phys, 48, 1281, 10.1016\u002FS0360-3016(00)01378-X\nWoodward, 2010, Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival, Breast Cancer Res Treat, 123, 597, 10.1007\u002Fs10549-010-0829-8\nBuchanan, 2006, Locoregional recurrence after mastectomy: incidence and outcomes, J Am Coll Surg, 203, 469, 10.1016\u002Fj.jamcollsurg.2006.06.015\nHarris, 2003, Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy, Cancer, 98, 2144, 10.1002\u002Fcncr.11767\nReddy, 2010, Long-term outcomes in patients with isolated supraclavicular nodal recurrence after mastectomy and doxorubicin-based chemotherapy for breast cancer, Int J Radiat Oncol Biol Phys, 80, 1453, 10.1016\u002Fj.ijrobp.2010.04.015\nJaffre, 2009, Prognosis for isolated skin recurrence after breast cancer treated by mastectomy, Anticancer Res, 29, 1697\nBurstein, 2004, Ductal carcinoma in situ of the breast, N Engl J Med, 350, 1430, 10.1056\u002FNEJMra031301\nBoyages, 1999, Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis, Cancer, 85, 616, 10.1002\u002F(SICI)1097-0142(19990201)85:3\u003C616::AID-CNCR12>3.0.CO;2-7\nWapnir, 2011, Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS, J Natl Cancer Inst, 103, 478, 10.1093\u002Fjnci\u002Fdjr027\nFisher, 2001, Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience, Semin Oncol, 28, 400, 10.1016\u002FS0093-7754(01)90133-2\nBijker, 2006, J Clin Oncol, 24, 3381, 10.1200\u002FJCO.2006.06.1366\nHolmberg, 2008, Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast, J Clin Oncol, 26, 1247, 10.1200\u002FJCO.2007.12.7969\nHoughton, 2003, Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial, Lancet, 362, 95, 10.1016\u002FS0140-6736(03)13859-7\nViani, 2007, Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials, Radiat Oncol, 2, 28, 10.1186\u002F1748-717X-2-28\nSilverstein, 1999, The influence of margin width on local control of ductal carcinoma in situ of the breast, N Engl J Med, 340, 1455, 10.1056\u002FNEJM199905133401902\nSilverstein, 1996, A prognostic index for ductal carcinoma in situ of the breast, Cancer, 77, 2267, 10.1002\u002F(SICI)1097-0142(19960601)77:11\u003C2267::AID-CNCR13>3.0.CO;2-V\nWong, 2006, Prospective study of wide excision alone for ductal carcinoma in situ of the breast, J Clin Oncol, 24, 1031, 10.1200\u002FJCO.2005.02.9975\nHughes, 2009, Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group, J Clin Oncol, 27, 5319, 10.1200\u002FJCO.2009.21.8560\nMotwani, 2011, Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194, Cancer, 117, 1156, 10.1002\u002Fcncr.25623\nKrag, 2007, Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial, Lancet Oncol, 8, 881, 10.1016\u002FS1470-2045(07)70278-4\nVeronesi, 2003, A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Engl J Med, 349, 546, 10.1056\u002FNEJMoa012782\nNaik, 2004, The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures, Ann Surg, 240, 462, 10.1097\u002F01.sla.0000137130.23530.19\nvan der Ploeg, 2008, Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature, Eur J Surg Oncol, 34, 1277, 10.1016\u002Fj.ejso.2008.01.034\nKrag, 2010, Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol, 11, 927, 10.1016\u002FS1470-2045(10)70207-2\nDel Bianco, 2008, Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial, Eur J Surg Oncol, 34, 508, 10.1016\u002Fj.ejso.2007.05.017\nFisher, 1981, The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast, Surg Gynecol Obstet, 152, 765\nGoyal, 2004, Predictors of non-sentinel lymph node metastasis in breast cancer patients, Eur J Cancer, 40, 1731, 10.1016\u002Fj.ejca.2004.04.006\nHwang, 2003, Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer, Ann Surg Oncol, 10, 248, 10.1245\u002FASO.2003.05.020\nNos, 2003, Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases, Br J Surg, 90, 1354, 10.1002\u002Fbjs.4325\nAlran, 2007, Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy, Ann Surg Oncol, 14, 2195, 10.1245\u002Fs10434-006-9331-2\nHouvenaeghel, 2009, A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis, Eur J Surg Oncol, 35, 690, 10.1016\u002Fj.ejso.2008.10.003\nVan Zee, 2003, A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy, Ann Surg Oncol, 10, 1140, 10.1245\u002FASO.2003.03.015\nCoutant, 2009, Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study, Breast Cancer Res Treat, 113, 537, 10.1007\u002Fs10549-008-9967-7\nPark, 2007, A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram, Ann Surg, 245, 462, 10.1097\u002F01.sla.0000250439.86020.85\nGrube, 2001, Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial, Semin Surg Oncol, 20, 230, 10.1002\u002Fssu.1038\nGiuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, 305, 569, 10.1001\u002Fjama.2011.90\nBeadle, 2009, Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach, Int J Radiat Oncol Biol Phys, 73, 734, 10.1016\u002Fj.ijrobp.2008.04.078\nTruong, 2009, Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy, Int J Radiat Oncol Biol Phys, 73, 357, 10.1016\u002Fj.ijrobp.2008.04.034\nVoogd, 2001, Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials, J Clin Oncol, 19, 1688, 10.1200\u002FJCO.2001.19.6.1688\nGentilini, 2007, When can a second conservative approach be considered for ipsilateral breast tumour recurrence?, Ann Oncol, 18, 468, 10.1093\u002Fannonc\u002Fmdl424\nOh, 2006, The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: how young is “young”?, Int J Radiat Oncol Biol Phys, 65, 1345, 10.1016\u002Fj.ijrobp.2006.03.028\nGarg, 2007, Effect of postmastectomy radiotherapy in patients \u003C 35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy, Int J Radiat Oncol Biol Phys, 69, 1478, 10.1016\u002Fj.ijrobp.2007.05.029\nPark, 2009, High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer, Int J Radiat Oncol Biol Phys, 73, 75, 10.1016\u002Fj.ijrobp.2008.04.007\nEwertz, 2011, Effect of obesity on prognosis after early-stage breast cancer, J Clin Oncol, 29, 25, 10.1200\u002FJCO.2010.29.7614\nGabos, 2010, The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer, Breast Cancer Res Treat, 124, 187, 10.1007\u002Fs10549-010-1135-1\nLi, 2011, Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 chinese breast cancer cases, Ann Surg Oncol, 18, 2492, 10.1245\u002Fs10434-011-1626-2\nSinn, 1998, Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy, Eur J Cancer, 34, 646, 10.1016\u002FS0959-8049(97)10106-X\nHolland, 1990, The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast, J Clin Oncol, 8, 113, 10.1200\u002FJCO.1990.8.1.113\nAlbert, 2010, Estrogen\u002Fprogesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer, Int J Radiat Oncol Biol Phys, 77, 1296, 10.1016\u002Fj.ijrobp.2009.12.011\nPanoff, 2011, Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation, Breast Cancer Res Treat, 128, 899, 10.1007\u002Fs10549-011-1495-1\nMeyers, 2011, Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer, Ann Surg Oncol, 18, 2851, 10.1245\u002Fs10434-011-1665-8\nMontagna, 2012, Breast cancer subtypes and outcome after local and regional relapse, Ann Oncol, 23, 324, 10.1093\u002Fannonc\u002Fmdr129\nFreedman, 2009, Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation, Cancer, 115, 946, 10.1002\u002Fcncr.24094\nVoduc, 2010, Breast cancer subtypes and the risk of local and regional relapse, J Clin Oncol, 28, 1684, 10.1200\u002FJCO.2009.24.9284\nAlbert, 2011, Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer, Cancer, 117, 1595, 10.1002\u002Fcncr.25694\nWang, 2010, Triple-negative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy, Int J Radiat Oncol Biol Phys, 80, 1095, 10.1016\u002Fj.ijrobp.2010.03.038\nKwan, 2010, Does HER2 status influence locoregional failure rates in breast cancer patients treated with mastectomy for pT1-2pN0 disease?, Ann Oncol, 21, 988, 10.1093\u002Fannonc\u002Fmdp396\nBidard, 2009, Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer, Ann Oncol, 20, 1836, 10.1093\u002Fannonc\u002Fmdp200\nHoussami, 2010, Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy, Eur J Cancer, 46, 3219, 10.1016\u002Fj.ejca.2010.07.043\nCuzick, 2011, Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\u002FANZ DCIS trial, Lancet Oncol, 12, 21, 10.1016\u002FS1470-2045(10)70266-7\nPetrelli, 2011, Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials, Radiother Oncol, 100, 195, 10.1016\u002Fj.radonc.2011.02.005\nMauri, 2005, Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis, J Natl Cancer Inst, 97, 188, 10.1093\u002Fjnci\u002Fdji021\nBuzdar, 2005, Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer, J Clin Oncol, 23, 3676, 10.1200\u002FJCO.2005.07.032\nLiedtke, 2008, Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer, J Clin Oncol, 26, 1275, 10.1200\u002FJCO.2007.14.4147\nChen, 2004, Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience, J Clin Oncol, 22, 2303, 10.1200\u002FJCO.2004.09.062\nAlpert, 2005, Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation, Int J Radiat Oncol Biol Phys, 63, 845, 10.1016\u002Fj.ijrobp.2005.02.035\nSchnitt, 1985, Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance, Int J Radiat Oncol Biol Phys, 11, 1277, 10.1016\u002F0360-3016(85)90242-1\nKurtz, 1991, Is breast conservation after local recurrence feasible?, Eur J Cancer, 27, 240, 10.1016\u002F0277-5379(91)90505-8\nVoogd, 1999, Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer, Eur J Cancer, 35, 1828, 10.1016\u002FS0959-8049(99)00220-8\nKomoike, 2003, Repeat lumpectomy for patients with ipsilateral breast tumor recurrence after breast-conserving surgery. Preliminary results, Oncology, 64, 1, 10.1159\u002F000066512\nKuerer, 2004, Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: the potential role of partial breast irradiation, Cancer, 100, 2269, 10.1002\u002Fcncr.20257\nDeutsch, 2002, Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation, Int J Radiat Oncol Biol Phys, 53, 687, 10.1016\u002FS0360-3016(02)02785-2\nTrombetta, 2008, Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience, Brachytherapy, 7, 29, 10.1016\u002Fj.brachy.2007.12.001\nChadha, 2008, The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer, Brachytherapy, 7, 22, 10.1016\u002Fj.brachy.2007.10.006\nResch, 2002, Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy–a second chance to preserve the breast, Radiology, 225, 713, 10.1148\u002Fradiol.2253011913\nHannoun-Levi, 2004, Partial breast irradiation as second conservative treatment for local breast cancer recurrence, Int J Radiat Oncol Biol Phys, 60, 1385, 10.1016\u002Fj.ijrobp.2004.05.035\nKuo, 2008, Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence, Int J Radiat Oncol Biol Phys, 72, 1456, 10.1016\u002Fj.ijrobp.2008.03.042\nBeck, 1983, Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients, J Clin Oncol, 1, 400, 10.1200\u002FJCO.1983.1.6.400\nHalverson, 1992, Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy, Am J Clin Oncol, 15, 93, 10.1097\u002F00000421-199204000-00001\nJanjan, 1986, Management of locoregional recurrent breast cancer, Cancer, 58, 1552, 10.1002\u002F1097-0142(19861001)58:7\u003C1552::AID-CNCR2820580728>3.0.CO;2-W\nWaeber, 2003, Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23\u002F82) comparing tamoxifen with observation, Ann Oncol, 14, 1215, 10.1093\u002Fannonc\u002Fmdg347\nBorner, 1994, First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation, J Clin Oncol, 12, 2071, 10.1200\u002FJCO.1994.12.10.2071\nRauschecker H, Clarke M, Gatzemeier W, Recht A. Systemic therapy for treating locoregional recurrence in women with breast cancer. Cochrane Database Syst Rev 2001;(4):CD002195.\nWapnir, 2008, Progress on BIG 1-02\u002FIBCSG 27-02\u002FNSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer, Ann Surg Oncol, 15, 3227, 10.1245\u002Fs10434-008-0129-2",{"ES":1160},"Recidivas locorregionales del cáncer de mama",{"VOID":1162},"10.1016\u002Fs1283-081x(14)66862-4","2025-02-09T14:37:55.954+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X14668624",[1166,1181],{"id":1167,"sortIndex":36,"researcher":26,"roles":1168,"affiliations":1169,"properties":1178},"bedba40a-3979-43ad-b0cf-3b4f60d1975c",[696],[1170],{"id":26,"sortIndex":36,"affiliation":1171,"properties":26},{"id":1172,"createTime":1173,"updateTime":1173,"relativeEntities":1174,"slug":26,"properties":1175,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1af7c9b7-d117-4930-b430-407dadbf1572","2024-01-26T07:49:12.027+00:00",[],{"title":1176},{"VI":1177},"Chirurgie oncologique et reconstructrice, ICM Val d’Aurelle, 34298 Montpellier, France",{"title":1179},{"VI":1180},"P.-E. Colombo",{"id":1182,"sortIndex":115,"researcher":26,"roles":1183,"affiliations":1184,"properties":1190},"56342c95-1400-492a-b5f4-6dd7db30b676",[696],[1185],{"id":26,"sortIndex":36,"affiliation":1186,"properties":26},{"id":1172,"createTime":1173,"updateTime":1173,"relativeEntities":1187,"slug":26,"properties":1188,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1189},{"VI":1177},{"title":1191},{"VI":1192},"P. Rouanet",{"url":1164,"publisher":1194,"properties":1202},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1195,"slug":662,"properties":1196,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1199,"manageAffiliations":1200,"indexDatabases":1201,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1197,"title":1198},{"VOID":665},{"EN":667},[],[],[],{"volume":1203,"pages":1205},{"VOID":1204},"50",{"VOID":946},"2014-03-01",2014,{"id":1209,"createTime":1210,"updateTime":1211,"relativeEntities":1212,"slug":1213,"properties":1214,"entityType":688,"verifyStatus":25,"verifyTime":1211,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":1221,"fullTextUrl":26,"authors":1222,"publicationType":747,"publisherRelationship":1294,"citationCount":26,"citationInfo":26,"publishDate":1307,"publishYear":992,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"026c9691-1dae-44b9-a2f8-c55c97b73d3f","2024-02-13T14:54:18.979+00:00","2025-01-27T08:28:40.330+00:00",[],"Histeroscopia-quir%C3%BArgica",{"references":1215,"title":1217,"doi":1219},{"VOID":1216},"Neveu, 2017, Standardizing hysteroscopy teaching: development of a curriculum using the Delphi method, Surg Endosc, 31, 5389, 10.1007\u002Fs00464-017-5620-z\nLopes, 2017, An overview of the results of hysterosonography prior to in vitro fertilization, JBRA Assist Reprod, 21, 302\nBouzid, 2016, Feasibility and diagnostic value of hysterosonography performed in bleeding time in the exploration of abnormal uterine bleeding, J Gynecol Obstet Biol Reprod, 45, 1067, 10.1016\u002Fj.jgyn.2016.03.008\nde Kroon, 2003, Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis, Int J Obstet Gynaecol, 110, 938, 10.1111\u002Fj.1471-0528.2003.02472.x\nDudiak, 2001, Hysterosonography: a key to what is inside the uterus, Ultrasound Q, 17, 73, 10.1097\u002F00013644-200106000-00002\nDeffieux, 2013, Prevention of the complications related to hysteroscopy: guidelines for clinical practice, J Gynecol Obstet Biol Reprod, 42, 1032, 10.1016\u002Fj.jgyn.2013.09.008\nDreisler, 2019, Asherman's syndrome: current perspectives on diagnosis and management, Int J Womens Health, 11, 191, 10.2147\u002FIJWH.S165474\nSalle, 1999, Transvaginal sonohysterographic evaluation of intrauterine adhesions, J Clin Ultrasound, 27, 131, 10.1002\u002F(SICI)1097-0096(199903\u002F04)27:3\u003C131::AID-JCU5>3.0.CO;2-3\nSoares, 2000, Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases, Fertil Steril, 73, 406, 10.1016\u002FS0015-0282(99)00532-4\nBerridge, 2004, Saline infusion sonohysterography: technique, indications, and imaging findings, J Ultrasound Med, 23, 97, 10.7863\u002Fjum.2004.23.1.97\nSabry, 2018, Diagnostic value of three-dimensional saline infusion sonohysterography in the evaluation of the uterus and uterine cavity lesions, Pol J Radiol, 83, e482, 10.5114\u002Fpjr.2018.80132\nWamsteker, 1988, Diagnostic and therapeutic applications of hysteroscopy, Ned Tijdschr Geneeskd, 132, 2041\nCapella-Allouc, 1999, Hysteroscopic treatment of severe Asherman's syndrome and subsequent fertility, Hum Reprod, 14, 1230, 10.1093\u002Fhumrep\u002F14.5.1230\nFernandez, 2012, Total adhesions treated by hysteroscopy: must we stop at two procedures?, Fertil Steril, 98, 980, 10.1016\u002Fj.fertnstert.2012.06.032\nThubert, 2015, Influence of auto-cross-linked hyaluronic acid gel on pregnancy rate and hysteroscopic outcomes following surgical removal of intra-uterine adhesions, Eur J Obstet Gynecol Reprod Biol, 193, 65, 10.1016\u002Fj.ejogrb.2015.06.025\nWarembourg, 2015, Prevention and treatment of intra-uterine synechiae: review of the literature, J Gynecol Obstet Biol Reprod, 44, 366, 10.1016\u002Fj.jgyn.2014.10.014\nZhang, 2018, Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase, Stem Cell Res Ther, 9, 36, 10.1186\u002Fs13287-018-0777-5\nFernandez, 2012, Post-curettage and aspiration synechiae: is there value in an anti-adhesion agent?, J Gynecol Obstet Biol Reprod, 41, H8, 10.1016\u002FS0368-2315(12)70004-2\nGrimbizis, 2013, The ESHRE-ESGE consensus on the classification of female genital tract congenital anomalies, Gynecol Surg, 10, 199, 10.1007\u002Fs10397-013-0800-x\nRikken, 2018, The randomised uterine septum transsection trial (TRUST): design and protocol, BMC Womens Health, 18, 1, 10.1186\u002Fs12905-018-0637-6\nGarbin, 1997, Transcervical hysteroplasty: indications, techniques and results. 125 cases, Contracept Fertil Sex, 25, 843\nNagel, 1993, Hysteroscopic metroplasty in the diethylstilbestrol-exposed uterus and similar nonfusion anomalies: effects on subsequent reproductive performance; a preliminary report, Fertil Steril, 59, 502, 10.1016\u002FS0015-0282(16)55789-6\nFernandez, 2011, Surgical approach to and reproductive outcome after surgical correction of a T-shaped uterus, Hum Reprod, 26, 1730, 10.1093\u002Fhumrep\u002Fder056\nGarbin, 1998, Hysteroscopic metroplasty in diethylstilboestrol-exposed and hypoplastic uterus: a report on 24 cases, Hum Reprod, 13, 2751, 10.1093\u002Fhumrep\u002F13.10.2751\nMcIlwaine, 2015, A prospective study of the use of the Myosure resectoscope to manage endometrial polyps in an outpatient setting, Aust N Z J Obstet Gynaecol, 55, 482, 10.1111\u002Fajo.12382\nNoventa, 2015, Intrauterine morcellator devices: the icon of hysteroscopic future or merely a marketing image? A systematic review regarding safety, efficacy, advantages, and contraindications, Reprod Sci, 22, 1289, 10.1177\u002F1933719115578929\nScheiber, 2016, A prospective multicenter registry of patients undergoing hysteroscopic morcellation of uterine polyps and myomas, J Gynecol Surg, 32, 318, 10.1089\u002Fgyn.2016.0008\nRodriguez, 2019, Endometrial resection and ablation techniques for heavy menstrual bleeding, Cochrane Database Syst Rev\nKalampokas, 2018, Endometrial cancer after endometrial ablation or resection for menorrhagia, Int J Gynaecol Obstet, 142, 84, 10.1002\u002Fijgo.12503\nPhilip, 2018, Evaluation of NovaSure® global endometrial ablation in symptomatic adenomyosis: a longitudinal study with a 36 month-follow-up, Eur J Obstet Gynecol Reprod Biol, 227, 46, 10.1016\u002Fj.ejogrb.2018.04.001\nLou, 2019, The second generation endometrial ablation (NovaSure) improves efficacy of levonorgestrel-releasing intrauterine system in management of adenomyosis, Zhejiang Univ Med Sci, 48, 136\nThiel, 2014, Evaluation of the Novasure endometrial ablation procedure in women with uterine cavity length over 10cm, J Obstet Gynaecol Can, 36, 491, 10.1016\u002FS1701-2163(15)30562-4\nCooper, 2019, Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial, Lancet, 394, 1425, 10.1016\u002FS0140-6736(19)31790-8\nFlorio, 2012, Hysteroscopic treatment of the cesarean-induced isthmocele in restoring infertility, Curr Opin Obstet Gynecol, 24, 180, 10.1097\u002FGCO.0b013e3283521202\nCalzolari, 2019, Prevalence of infertility among patients with isthmocele and fertility outcome after isthmocele surgical treatment: a retrospective study, Ochsner J, 19, 204, 10.31486\u002Ftoj.18.0048\nMunro, 2011, The flexible FIGO classification concept for underlying causes of abnormal uterine bleeding, Semin Reprod Med, 29, 391, 10.1055\u002Fs-0031-1287663\nBettocchi, 2009, A new hysteroscopic technique for the preparation of partially intramural myomas in office setting (OPPIuM technique): a pilot study, J Minim Invasive Gynecol, 16, 748, 10.1016\u002Fj.jmig.2009.07.016\nFernandez, 2011, Update on the management of menometrorrhagia: new surgical approaches, Gynecol Endocrinol, 27, 1131, 10.3109\u002F09513590.2011.634261\nDi SpiezioSardo, 2017, The role of hysteroscopy in the diagnosis and treatment of adenomyosis, BioMed Res Int, 2017, e2518396, 10.1155\u002F2017\u002F2518396\nGeorgiou, 2018, Hysteroscopic tissue removal system (MyoSure) for the resection of polyps, sub-mucosal leiomyomas and retained products of conception in an out-patient setting: a single UK institution experience, Eur J Obstet Gynecol Reprod Biol, 231, 147, 10.1016\u002Fj.ejogrb.2018.10.030\nFaivre, 2009, Hysteroscopic management of residual trophoblastic tissue and reproductive outcome: a pilot study, J Minim Invasive Gynecol, 16, 487, 10.1016\u002Fj.jmig.2009.04.011\nRein, 2011, Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage, J Minim Invasive Gynecol, 18, 774, 10.1016\u002Fj.jmig.2011.08.003\nGulec, 2010, Osseous metaplasia of the endometrium, BMJ Case Rep, 2010, 10.1136\u002Fbcr.04.2010.2931\nGrigore, 2018, Ultrasound features of osseous metaplasia of the endometrium – Case series and review of the literature, Clin Imaging, 52, 260, 10.1016\u002Fj.clinimag.2018.08.006\nMadaan, 2015, Osseous metaplasia of the endometrium and successful hysteroscopic resection: a report of two cases and a review of the literature, Asian J Endosc Surg, 8, 63, 10.1111\u002Fases.12153\nCarin, 2015, Intra uterine devices removal during office hysteroscopy: about 36 cases, J Gynecol Obstet Biol Reprod, 44, 653, 10.1016\u002Fj.jgyn.2014.09.005",{"ES":1218},"Histeroscopia quirúrgica",{"VOID":1220},"10.1016\u002Fs1283-081x(22)46715-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X22467154",[1223,1238,1250,1262],{"id":1224,"sortIndex":114,"researcher":26,"roles":1225,"affiliations":1226,"properties":1235},"f42177e7-b479-4a2e-9318-73c4c4f0608d",[696],[1227],{"id":26,"sortIndex":36,"affiliation":1228,"properties":26},{"id":1229,"createTime":1230,"updateTime":1230,"relativeEntities":1231,"slug":26,"properties":1232,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"447a96c6-b3eb-4b3c-b24e-d1019f48f79f","2024-02-12T14:44:19.701+00:00",[],{"title":1233},{"VI":1234},"Service de gynécologie obstétrique, Hôpital Bicêtre, GHU Sud, AP–HP, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France",{"title":1236},{"VI":1237},"E. Debras",{"id":1239,"sortIndex":115,"researcher":26,"roles":1240,"affiliations":1241,"properties":1247},"1bffe931-a68d-4358-ae05-5b3497e7d37f",[696],[1242],{"id":26,"sortIndex":36,"affiliation":1243,"properties":26},{"id":1229,"createTime":1230,"updateTime":1230,"relativeEntities":1244,"slug":26,"properties":1245,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1246},{"VI":1234},{"title":1248},{"VI":1249},"S. Vigoureux",{"id":1251,"sortIndex":36,"researcher":26,"roles":1252,"affiliations":1253,"properties":1259},"4109171b-e2c5-4a04-98ac-ee4dfe0f756a",[696],[1254],{"id":26,"sortIndex":36,"affiliation":1255,"properties":26},{"id":1229,"createTime":1230,"updateTime":1230,"relativeEntities":1256,"slug":26,"properties":1257,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1258},{"VI":1234},{"title":1260},{"VI":1261},"M.-E. Neveu",{"id":1263,"sortIndex":59,"researcher":26,"roles":1264,"affiliations":1265,"properties":1291},"3ccd3418-a9dd-409e-a1c0-f1e2849ae686",[696],[1266,1276,1286],{"id":1267,"sortIndex":114,"affiliation":1268,"properties":1275},"31269e30-8572-4937-97e0-a4c30526b401",{"id":1269,"createTime":1270,"updateTime":1270,"relativeEntities":1271,"slug":26,"properties":1272,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"85ab7473-d560-4a7c-b8ee-07b3c7158319","2024-02-12T14:44:19.745+00:00",[],{"title":1273},{"VI":1274},"Centre de recherche en épidémiologie et santé des populations, Inserm, UVSQ, Université Paris-Saclay, 94807 Villejuif, France",{},{"id":1277,"sortIndex":115,"affiliation":1278,"properties":1285},"1fd9180a-6435-497b-a139-2fe7a0e28323",{"id":1279,"createTime":1280,"updateTime":1280,"relativeEntities":1281,"slug":26,"properties":1282,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"bcca5d0d-f493-42cd-8de7-5ca1467a4950","2023-12-11T17:31:33.619+00:00",[],{"title":1283},{"VI":1284},"Faculté de médecine Paris-Sud Saclay, 63, rue Gabriel-Péri, 94270 Le Kremlin-Bicêtre, France",{},{"id":26,"sortIndex":36,"affiliation":1287,"properties":26},{"id":1229,"createTime":1230,"updateTime":1230,"relativeEntities":1288,"slug":26,"properties":1289,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1290},{"VI":1234},{"title":1292},{"VI":1293},"H. Fernandez",{"url":1221,"publisher":1295,"properties":1303},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1296,"slug":662,"properties":1297,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1300,"manageAffiliations":1301,"indexDatabases":1302,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1298,"title":1299},{"VOID":665},{"EN":667},[],[],[],{"volume":1304,"pages":1305},{"VOID":988},{"VOID":1306},"1-21","2022-07-01",{"id":1309,"createTime":1310,"updateTime":1311,"relativeEntities":1312,"slug":1313,"properties":1314,"entityType":688,"verifyStatus":25,"verifyTime":1311,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1321,"fullTextUrl":26,"authors":1322,"publicationType":747,"publisherRelationship":1425,"citationCount":26,"citationInfo":26,"publishDate":991,"publishYear":992,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"4100459d-6ddb-4709-837d-a0ce7de0f9ee","2024-01-20T11:51:32.052+00:00","2024-12-06T07:26:45.401+00:00",[],"Epidemiolog%C3%ADa-y-prevenci%C3%B3n-primaria-y-secundaria-del-c%C3%A1ncer-de-c%C3%A9rvix",{"references":1315,"title":1317,"doi":1319},{"VOID":1316},"Defossez, 2019\nRonco, 2014, Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials, Lancet, 383, 524, 10.1016\u002FS0140-6736(13)62218-7\nMcNall, 2004, Adenocarcinoma of the cervix and vagina in pediatric patients, Pediatr Blood Cancer, 43, 289, 10.1002\u002Fpbc.20113\nBurd, 2003, Human papillomavirus and cervical cancer, Clin Microbiol Rev, 16, 1, 10.1128\u002FCMR.16.1.1-17.2003\nLorincz, 1992, Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types, Obstet Gynecol, 79, 328, 10.1097\u002F00006250-199203000-00002\nEgawa, 2017, The low-risk papillomaviruses, Virus Res, 231, 119, 10.1016\u002Fj.virusres.2016.12.017\nHandsfield, 1997, Clinical presentation and natural course of anogenital warts, Am J Med, 102, 16, 10.1016\u002FS0002-9343(97)00179-4\nMunoz, 2004, Against which human papillomavirus types shall we vaccinate and screen? The international perspective, Int J Cancer, 111, 278, 10.1002\u002Fijc.20244\nde Villiers, 2004, Classification of papillomaviruses, Virology, 324, 17, 10.1016\u002Fj.virol.2004.03.033\nDalstein, 2003, Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study, Int J Cancer, 106, 396, 10.1002\u002Fijc.11222\nDunne, 2007, Prevalence of HPV infection among females in the United States, JAMA, 297, 813, 10.1001\u002Fjama.297.8.813\nDaling, 2002, A population-based study of squamous cell vaginal cancer: HPV and cofactors, Gynecol Oncol, 84, 263, 10.1006\u002Fgyno.2001.6502\nChan, 2003, HPV infection and number of lifetime sexual partners are strong predictors for ‘natural’ regression of CIN2 and 3, Br J Cancer, 89, 1062, 10.1038\u002Fsj.bjc.6601196\nMcIntyre-Seltman, 2005, Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology, Cancer Epidemiol Biomarkers Prev, 14, 1165, 10.1158\u002F1055-9965.EPI-04-0918\nTrimble, 2005, Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype, Clin Cancer Res, 11, 4717, 10.1158\u002F1078-0432.CCR-04-2599\nBrown, 2019, Genetic susceptibility to cervical neoplasia, Papillomavirus Res, 7, 132, 10.1016\u002Fj.pvr.2019.04.002\nInternational Collaboration of Epidemiological Studies of Cervical Cancer, 2006, Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies, Int J Cancer, 119, 1108, 10.1002\u002Fijc.21953\nInternational Collaboration of Epidemiological Studies of Cervical Cancer, 2007, Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies, Lancet, 370, 1609, 10.1016\u002FS0140-6736(07)61684-5\nCuzick, 2006, Overview of the European and North American studies on HPV testing in primary cervical cancer screening, Int J Cancer, 119, 1095, 10.1002\u002Fijc.21955\nCollins, 2002, High incidence of cervical human papillomavirus infection in women during their first sexual relationship, Bjog, 109, 96, 10.1111\u002Fj.1471-0528.2002.01053.x\nEdgren, 2007, Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study, Lancet Oncol, 8, 311, 10.1016\u002FS1470-2045(07)70043-8\nBertoli, 2020, Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: a population- based prospective cohort study, Gynecol Oncol, 157, 456, 10.1016\u002Fj.ygyno.2020.01.030\nJudson, 2006, Trends in the incidence of invasive and in situ vulvar carcinoma, Obstet Gynecol, 107, 1018, 10.1097\u002F01.AOG.0000210268.57527.a1\nLukasiewicz, 2002, Incidence and management of condylomata acuminata by French general physicians, Ann Dermatol Venereol, 129, 991\nMonsonego, 2007, Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France, Gynecol Obstet Fertil, 35, 107\nFrisch, 1999, Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses, Cancer Res, 59, 753\nHeim, 2005, Specific serologic response to genital human papillomavirus types in patients with vulvar precancerous and cancerous lesions, Am J Obstet Gynecol, 192, 1073, 10.1016\u002Fj.ajog.2004.09.130\nDarragh, 2013, The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology, Int J Gynecol Pathol, 32A, 76, 10.1097\u002FPGP.0b013e31826916c7\nEgawa, 2015, Human papillomaviruses; epithelial tropisms, and the development of neoplasia, Viruses, 7, 3863, 10.3390\u002Fv7072802\nHerrero, 2005, Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica, J Infect Dis, 191, 1796, 10.1086\u002F428850\nKero, 2019, HPV infections in heterosexual couples: mechanisms and covariates of virus transmission, Acta Cytol, 63, 143, 10.1159\u002F000494710\nWiner, 2006, Condom use and the risk of genital human papillomavirus infection in young women, N Engl J Med, 354, 2645, 10.1056\u002FNEJMoa053284\nBurchell, 2010, Human papillomavirus infections among couples in new sexual relationships, Epidemiology, 21, 31, 10.1097\u002FEDE.0b013e3181c1e70b\nKum-Nji, 2019, Tobacco smoke exposure as a risk factor for human papillomavirus infections in women 18-26 years old in the United States, PLoS One, 14, e0223532, 10.1371\u002Fjournal.pone.0223532\nZhu, 2016, Chlamydia trachomatis infection-associated risk of cervical cancer: a meta-analysis, Medicine, 95, e3077, 10.1097\u002FMD.0000000000003077\nGuidry, 2017, The interaction between human papillomavirus and other viruses, Virus Res, 231, 139, 10.1016\u002Fj.virusres.2016.11.002\nCastellsague, 2006, Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention, J Natl Cancer Inst, 98, 303, 10.1093\u002Fjnci\u002Fdjj067\nRoura, 2016, The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort, PLoS One, ll, e0147029, 10.1371\u002Fjournal.pone.0147029\nGormley, 2012, Human papillomavirus-related genital disease in the immunocompromised host: part II, J Am Acad Dermatol, 66, 883e1, 10.1016\u002Fj.jaad.2010.12.050\nGormley, 2012, Human papillomavirus-related genital disease in the immunocompromised host: part I, J Am Acad Dermatol, 66, 867e1, 10.1016\u002Fj.jaad.2010.12.050\nBrotman rM, 2014, Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection, J Infect Dis, 210, 1723, 10.1093\u002Finfdis\u002Fjiu330\nKjaer, 2001, High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse), Cancer Epidemiol Biomarkers Prev, 10, 101\nGiuliano, 2011, Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study, Lancet, 377, 932, 10.1016\u002FS0140-6736(10)62342-2\nWiner, 2011, Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women, Cancer Epidemiol Biomarkers Prev, 20, 699, 10.1158\u002F1055-9965.EPI-10-1108\nRodriguez, 2010, Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\u002F3: critical role of duration of infection, J Natl Cancer Inst, 102, 315, 10.1093\u002Fjnci\u002Fdjq001\nCastle, 2009, Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2, Obstet Gynecol, 113, 18, 10.1097\u002FAOG.0b013e31818f5008\nMoscicki, 2010, Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women, Obstet Gynecol, 116, 1373, 10.1097\u002FAOG.0b013e3181fe777f\nBekos, 2018, Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis, Sci Rep, 8, 6383, 10.1038\u002Fs41598-018-24882-2\nPlummer, 2007, A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion, J Infect Dis, 195, 1582, 10.1086\u002F516784\nMoscicki Ab, 2010, The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types, Cancer Epidemiol Biomarkers Prev, 19, 2055, 10.1158\u002F1055-9965.EPI-10-0394\nSchiffman, 2005, The carcinogenicity of human papillomavirus types reflects viral evolution, Virology, 337, 76, 10.1016\u002Fj.virol.2005.04.002\nBulkmans, 2007, High-risk HPV type-specific clearance rates in cervical screening, Br J Cancer, 96, 1419, 10.1038\u002Fsj.bjc.6603653\nSchiffman, 2007, Human papillomavirus and cervical cancer, Lancet, 370, 890, 10.1016\u002FS0140-6736(07)61416-0\nGravitt, 2011, The known unknowns of HPV natural history, J Clin Invest, 121, 4593, 10.1172\u002FJCI57149\nRositch, 2012, Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women, Cancer Res, 72, 6183, 10.1158\u002F0008-5472.CAN-12-2635\nZielinski, 2001, HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears, Br J Cancer, 85, 398, 10.1054\u002Fbjoc.2001.1926\nRen, 2019, Prognostic and diagnostic validity of p16\u002FKi-67, HPV E6\u002FE7 mRNA, and HPV DNA in women with ASCUS: a follow-up study, Virol J, 16, 143, 10.1186\u002Fs12985-019-1251-4\nBalasubramaniam, 2019, Key molecular events in cervical cancer development, Medicina, 55\nWiner, 2005, Development and duration of human papillomavirus lesions, after initial infection, J Infect Dis, 191, 731, 10.1086\u002F427557\nJoura, 2014, Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease, Cancer Epidemiol Biomarkers Prev, 23, 1997, 10.1158\u002F1055-9965.EPI-14-0410\nTjalma, 2013, Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe, Int J Cancer, 132, 854, 10.1002\u002Fijc.27713\nKukimoto, 2015, Genetic variations of human papillomavirus type 16: implications for cervical carcinogenesis, Jpn J Infect Dis, 68, 169, 10.7883\u002Fyoken.JJID.2014.584\nSun, 2001, The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix, Gynecol Oncol, 83, 95, 10.1006\u002Fgyno.2001.6336\nInsinga, 2007, Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives, Cancer Epidemiol Biomarkers Prev, 16, 709, 10.1158\u002F1055-9965.EPI-06-0846\nCervical cancer statistics. https:\u002F\u002Fwww.cancerresearchuk.org\u002Fhealth-professional\u002Fcancer-statistics\u002Fstatistics-by-cancer-type\u002Fcervical- cancer#heading-One\nINCa, 2019\nOrumaa, 2019, Recent increase in incidence of cervical precancerous lesions in Norway: nationwide study from 1992 to 2016, Int J Cancer, 145, 2629, 10.1002\u002Fijc.32195\nFrance SP, 2020\nBarré, 2017, Caractérisation des femmes ne réalisant pas de dépistage du cancer du col de l’utérus par frottis cervico-utérin en France, Bull Epidemiol Hebd, 39\nBrisson, 2013, Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination, J Natl Cancer Inst, 105, 158, 10.1093\u002Fjnci\u002Fdjs638\nNayar, 2015, The Pap Test and Bethesda 2014. “The reports of my demise have been greatly exaggerated” (after a quotation from Mark Twain), Acta Cytol, 59, 121, 10.1159\u002F000381842\nMartin-Hirsch, 2013, Surgery for cervical intraepithelial neoplasia, Cochrane Database Syst Rev, CD001318\nMaura, 2017, Dépistage du cancer du col de l’utérus et actes associés chez les femmes de moins de 25 ans entre 2007 et 2013 en France : une étude sur les bases de données médico-administratives françaises, Bull Epidemiol Hebd, 32\nMaura, 2018, Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study, Eur J Cancer Prev, 27, 479, 10.1097\u002FCEJ.0000000000000360\nLiebrich, 2009, Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents, Eur J Gynaecol Oncol, 30, 45\nCastanon, 2013, Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years, Br J Cancer, 109, 35, 10.1038\u002Fbjc.2013.322\nBoulanger, 2007, Histoire cytologique des cancers du col utérin diagnostiqués en France en 2006, Gynecol Obstet Fertil, 35, 764, 10.1016\u002Fj.gyobfe.2007.07.019\nSasieni, 2003, Benefit of cervical screening at different ages: evidence from the UK audit of screening histories, Br J Cancer, 89, 88, 10.1038\u002Fsj.bjc.6600974\nLavoue, 2009, Histoire cytologique de 191 patientes atteintes d’un cancer invasif du col de l’utérus en région Bretagne, J Gynecol Obstet Biol Reprod, 38, 396, 10.1016\u002Fj.jgyn.2009.04.009\nArbyn, 2012, Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer, Vaccine, 30, F88, 10.1016\u002Fj.vaccine.2012.06.095\nAndrae, 2008, Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden, J Natl Cancer Inst, 100, 622, 10.1093\u002Fjnci\u002Fdjn099\nMeijer, 2009, Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older, Int J Cancer, 124, 516, 10.1002\u002Fijc.24010\nEide, 2012, HPV detection methods and genotyping techniques in screening for cervical cancer, Ann Pathol, 32, 401, 10.1016\u002Fj.annpat.2012.09.200\nArbyn, 2018, Collaboration on Self-Sampling and HPV Testing. Detecting cervical precancer and reaching underscreened women by using HPV testing on self-samples: updated meta-analyses, BMJ, 363, k4823, 10.1136\u002Fbmj.k4823\nMunoz, 2004, Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results, J Infect Dis, 190, 2077, 10.1086\u002F425907\nKorostil, 2014, The potential impact of HPV-16 reactivation on prevalence in older Australians, BMC Infect Dis, 14, 312, 10.1186\u002F1471-2334-14-312\nStroope, 2015, Marital characteristics and the sexual relationships of U.S. older adults: an analysis of national social life, health, and aging project data, Arch Sex Behav, 44, 233, 10.1007\u002Fs10508-014-0379-y\nBergengren, 2020, Prevalence of HPV and pathological changes among women 70 years of age, 10 years after exclusion from the Swedish cervical cancer screening program, Cancer Causes Control, 31, 377, 10.1007\u002Fs10552-020-01278-0\nBaldauf, 2019, Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program, Eur J Cancer Prev, 28, 33, 10.1097\u002FCEJ.0000000000000415\nHammer, 2018, Cervical cancer screening history prior to diagnosis of cervical cancer in Danish women aged 60 years old and older - A national cohort study, Cancer Med, 8, 418, 10.1002\u002Fcam4.1926\nCastanon, 2014, Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study, PLoS Med, 11, e1001585, 10.1371\u002Fjournal.pmed.1001585\nMeyer, 2012, Existe-t-il un intérêt à poursuivre les frottis de dépistage du cancer du col utérin après 65 ans ? Étude rétrospective sur 53 644 femmes, Bull Cancer, 99, 409, 10.1684\u002Fbdc.2012.1556\nHermansson, 2018, HPV prevalence and HPV-related dysplasia in elderly women, PLoS One, 13, e0189300, 10.1371\u002Fjournal.pone.0189300\nStokes-Lampard, 2006, Vaginal vault smears after hysterectomy for reasons other than malignancy: a systematic review of the literature, BJOG, 113, 1354, 10.1111\u002Fj.1471-0528.2006.01099.x\nNicolas, 2013, Faut-il pratiquer des frottis vaginaux après hystérectomie totale pour CIN3 ?, Gynecol Obstet Fertil, 41, 196, 10.1016\u002Fj.gyobfe.2013.01.009\nHAS, 2019\nANRSC, 2017\nCenters for Disease Control and Prevention, tNIoH, HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. http:\u002F\u002Faidsinfonihgov 2019.\nMoscicki, 2019, Guidelines for cervical cancer screening in immunosuppressed women without HIV infection, J Low Genit Tract Dis, 23, 87, 10.1097\u002FLGT.0000000000000468\nSchiller, 2004, Delivering on the promise: HPV vaccines and cervical cancer, Nat Rev Microbiol, 2, 343, 10.1038\u002Fnrmicro867\nArbyn, 2018, Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials, Expert Rev Vaccines, 17, 1085, 10.1080\u002F14760584.2018.1548282\nArbyn, 2018, Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors, Cochrane Database Syst Rev, CD009069\nLopalco, 2017, Spotlight on the 9-valent HPV vaccine, Drug Des Devel Ther, 11, 35, 10.2147\u002FDDDT.S91018\nHuh, 2017, Final efficacy, immunogenicity, and safety analyses of a ninevalent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial, Lancet, 390, 2143, 10.1016\u002FS0140-6736(17)31821-4\nDehlendorff, 2020, Real-world effectiveness of Human Papillomavirus vaccination against vulvovaginal high-grade pre-cancerous lesions and cancers, J Natl Cancer Inst\nLei, 2020, HPV vaccination and the risk of invasive cervical cancer, N Engl J Med, 383, 1340, 10.1056\u002FNEJMoa1917338\nEbisch, 2017, Long-lasting increased risk of human papillomavirus-related carcinomas and premalignancies after cervical intraepithelial neoplasia grade 3: a population-based cohort study, J Clin Oncol, 35, 2542, 10.1200\u002FJCO.2016.71.4543\nKalliala, 2020, Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature, Ann Oncol, 31, 213, 10.1016\u002Fj.annonc.2019.11.004\nLin, 2019, Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis, Lancet Infect Dis, 19, 880, 10.1016\u002FS1473-3099(19)30164-1\nJentschke, 2020, Prophylactic HPV vaccination after conization: a systematic review and meta-analysis, Vaccine, 38, 6402, 10.1016\u002Fj.vaccine.2020.07.055\nDrolet, 2019, Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis, Lancet, 394, 497, 10.1016\u002FS0140-6736(19)30298-3",{"ES":1318},"Epidemiología y prevención primaria y secundaria del cáncer de cérvix",{"VOID":1320},"10.1016\u002Fs1283-081x(22)47071-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X22470718",[1323,1338,1350,1362,1377,1389,1401],{"id":1324,"sortIndex":111,"researcher":26,"roles":1325,"affiliations":1326,"properties":1335},"44f08123-bfda-4d68-99d4-2bfd31d31b2a",[696],[1327],{"id":26,"sortIndex":36,"affiliation":1328,"properties":26},{"id":1329,"createTime":1330,"updateTime":1330,"relativeEntities":1331,"slug":26,"properties":1332,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6770ebdb-1f05-48f0-a9d9-285d52ff63fa","2024-01-20T11:51:32.216+00:00",[],{"title":1333},{"VI":1334},"Département de gynécologie obstétrique et reproduction humaine, CHU Anne-de-Bretagne, 16, boulevard de Bulgarie, 35203 Rennes cedex 2, France",{"title":1336},{"VI":1337},"K. Nyangoh-Timoh",{"id":1339,"sortIndex":36,"researcher":26,"roles":1340,"affiliations":1341,"properties":1347},"863d8c00-3f74-4770-b721-afcf5c9785a6",[696],[1342],{"id":26,"sortIndex":36,"affiliation":1343,"properties":26},{"id":1329,"createTime":1330,"updateTime":1330,"relativeEntities":1344,"slug":26,"properties":1345,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1346},{"VI":1334},{"title":1348},{"VI":1349},"L. Dion",{"id":1351,"sortIndex":115,"researcher":26,"roles":1352,"affiliations":1353,"properties":1359},"0fee9bca-2c7e-4b83-be19-84eb036dd5e7",[696],[1354],{"id":26,"sortIndex":36,"affiliation":1355,"properties":26},{"id":1329,"createTime":1330,"updateTime":1330,"relativeEntities":1356,"slug":26,"properties":1357,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1358},{"VI":1334},{"title":1360},{"VI":1361},"M. Mairé",{"id":1363,"sortIndex":59,"researcher":26,"roles":1364,"affiliations":1365,"properties":1374},"bb88777c-f89b-439e-b51c-c7ea126a3a83",[696],[1366],{"id":26,"sortIndex":36,"affiliation":1367,"properties":26},{"id":1368,"createTime":1369,"updateTime":1369,"relativeEntities":1370,"slug":26,"properties":1371,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"48806fb3-c4d2-4c81-8d98-d27ff67712ad","2023-12-06T10:49:32.907+00:00",[],{"title":1372},{"VI":1373},"Service de gynécologie obstétrique, Hôpital de Hautepierre, 1, avenue Molière, 67098 Strasbourg, France",{"title":1375},{"VI":1376},"J.-J. Baldauf",{"id":1378,"sortIndex":114,"researcher":26,"roles":1379,"affiliations":1380,"properties":1386},"455308a8-e84f-4cda-a550-5c7ed003cf55",[696],[1381],{"id":26,"sortIndex":36,"affiliation":1382,"properties":26},{"id":1368,"createTime":1369,"updateTime":1369,"relativeEntities":1383,"slug":26,"properties":1384,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1385},{"VI":1373},{"title":1387},{"VI":1388},"L. Lecointre",{"id":1390,"sortIndex":162,"researcher":26,"roles":1391,"affiliations":1392,"properties":1398},"04b09e20-9dd9-43ac-8b16-d480b767d683",[696],[1393],{"id":26,"sortIndex":36,"affiliation":1394,"properties":26},{"id":1329,"createTime":1330,"updateTime":1330,"relativeEntities":1395,"slug":26,"properties":1396,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1397},{"VI":1334},{"title":1399},{"VI":1400},"V. Lavoué",{"id":1402,"sortIndex":135,"researcher":26,"roles":1403,"affiliations":1404,"properties":1422},"ad230467-08fe-4629-b973-e70698d0c4be",[696],[1405,1417],{"id":1406,"sortIndex":115,"affiliation":1407,"properties":1416},"9e0c12fa-eae9-49fb-b2cb-909692c621fc",{"id":1408,"createTime":1409,"updateTime":1410,"relativeEntities":1411,"slug":1412,"properties":1413,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"06ce1d5c-8eeb-4d9f-a588-f9af43b6a252","2024-01-20T11:51:32.267+00:00","2025-06-11T19:51:51.306+00:00",[],"Soci%C3%A9t%C3%A9-fran%C3%A7aise-de-colposcopie-et-pathologie-cervico-vaginale-64-rue-de-Rennes-75006-Paris-France",{"title":1414},{"VI":1415},"Société française de colposcopie et pathologie cervico-vaginale, 64, rue de Rennes, 75006 Paris, France",{},{"id":26,"sortIndex":36,"affiliation":1418,"properties":26},{"id":1329,"createTime":1330,"updateTime":1330,"relativeEntities":1419,"slug":26,"properties":1420,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1421},{"VI":1334},{"title":1423},{"VI":1424},"J. Levêque",{"url":1321,"publisher":1426,"properties":1434},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1427,"slug":662,"properties":1428,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1431,"manageAffiliations":1432,"indexDatabases":1433,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1429,"title":1430},{"VOID":665},{"EN":667},[],[],[],{"volume":1435,"pages":1436},{"VOID":988},{"VOID":946},{"id":1438,"createTime":1439,"updateTime":1440,"relativeEntities":1441,"slug":1442,"properties":1443,"entityType":688,"verifyStatus":25,"verifyTime":1450,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1451,"fullTextUrl":26,"authors":1452,"publicationType":747,"publisherRelationship":1468,"citationCount":26,"citationInfo":26,"publishDate":1482,"publishYear":1483,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"3b1d8019-a3c1-46b7-9afd-8f42ca0a04d1","2024-01-12T08:48:08.376+00:00","2025-01-14T04:11:22.357+00:00",[],"Carcinoma-mamario-in-situ",{"references":1444,"title":1446,"doi":1448},{"VOID":1445},"Andersen, 1974, Lobular carcinoma in situ, Acta Pathol Microbiol Scand, 82, 519\nAndersen, 1977, Lobular carcinoma in situ of the breast: an approach to rational treatment, Cancer, 39, 2597, 10.1002\u002F1097-0142(197706)39:6\u003C2597::AID-CNCR2820390644>3.0.CO;2-E\n1997, Consensus conference on the classification of ductal carcinoma in situ, Hum Pathol, 28, 1221, 10.1016\u002FS0046-8177(97)90193-3\nArnesson, 1989, Follow-up of two treatment modalities for ductal cancer in situ of the breast, Br J Surg, 76, 672, 10.1002\u002Fbjs.1800760707\nBerg, 1997, Evaluation of 14 and 11 gauges directional, vacuum assisted biopsy probes and 14 gauges biopsy guns in a breast parenchymal model, Radiology, 205, 203, 10.1148\u002Fradiology.205.1.9314986\nBetsill, 1978, Intraductal carcinoma: long-term follow-up after treatment by biopsy alone, JAMA, 239, 1863, 10.1001\u002Fjama.1978.03280450035020\nBoyages, 1999, Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis, Cancer, 85, 616, 10.1002\u002F(SICI)1097-0142(19990201)85:3\u003C616::AID-CNCR12>3.0.CO;2-7\nBurbank, 1997, Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional vacuum-assisted biopsy, Radiology, 202, 843, 10.1148\u002Fradiology.202.3.9051043\nCooke, 1989, Ductal carcinoma in situ: a new clinical problem, Br J Surg, 76, 660, 10.1002\u002Fbjs.1800760703\nCutuli, 1998, Lobular carcinoma in situ of the breast: results of a radiosurgical conservative treatment, Oncol Rep, 5, 1531\nDouglas-Jones, 1996, A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast: correlation with grade of associated invasive cancer, Histopathotogy, 29, 397, 10.1046\u002Fj.1365-2559.1996.d01-513.x\nErnster, 1997, Increases in ductal carcinoma in situ of the breast in relation to mammography: a dilemna, J Natl Cancer Inst Monogr, 22, 151, 10.1093\u002Fjncimono\u002F1997.22.151\nEusebi, 1994, Long-term follow-upof in situ carcinoma of the breast, Semin Diagn Pathol, 11, 223\nEvans, 1994, Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings, AJR Am J Roentgenol, 162, 1307, 10.2214\u002Fajr.162.6.8191988\nFentiman, 1989, The treatment of in situ breast cancer, Acta Oncol, 28, 923, 10.3109\u002F02841868909092333\nFisher, 1999, Highlights from recent NSABP studies in the treatment and prevention of breast cancer, CA CancerJ Clin, 49, 145\nFisher, 1998, Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and Bowel Project B-17, J Clin Oncol, 16, 441, 10.1200\u002FJCO.1998.16.2.441\nFisher, 1999, Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and Bowel Project B-24 randomised controlled trial, Lancet, 353, 1993, 10.1016\u002FS0140-6736(99)05036-9\nFisher, 1986, Pathologic findings from the national surgical adjuvant breast project (protocol 6). I: intraductal carcinoma, Cancer, 57, 197, 10.1002\u002F1097-0142(19860115)57:2\u003C197::AID-CNCR2820570203>3.0.CO;2-N\nFisher, 1999, Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach, Radiology, 213, 881, 10.1148\u002Fradiology.213.3.r99dc01881\nFoote, 1940, Lobular carcinoma in situ, Am J Pathol, 17, 491\nFrykberg, 1993, In situ breast carcinoma, Adv Surg, 26, 29\nGilles, 1994, Non palpable breast tumours: diagnosis with contrast-enhanced subtaction dynamic MR imaging, Radiology, 190, 825\nGilles, 1995, Ductal carcinoma in situ: MR imaging-histopathologic correlation, Radiology, 196, 415, 10.1148\u002Fradiology.196.2.7617854\nHaagensen, 1978, Lobular neoplasia (so-called lobularcarcinoma in situ) of the breast, Concert, 42, 737, 10.1002\u002F1097-0142(197808)42:2\u003C737::AID-CNCR2820420247>3.0.CO;2-T\nHolland, 1990, Extent, distribution and mammographic\u002Fhistological correlations of breast ductal carcinoma in situ, Lancet, 335, 519, 10.1016\u002F0140-6736(90)90747-S\nHolland, 1994, Ductal carcinoma in situ: a proposal for a new classification, Semin Diagn Patbol, 11, 167\nHutter, 1969, Lobular carcinoma in situ: long-term follow-up, Cancer, 24, 1081, 10.1002\u002F1097-0142(196911)24:5\u003C1081::AID-CNCR2820240534>3.0.CO;2-D\nJackman, 1999, Stereotactic, automated, large-core needle biopsy of non palpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up, Radiology, 210, 799, 10.1148\u002Fradiology.210.3.r99mr19799\nJulien, 2000, Radiotherapy in breast-conservating treatment for ductal carcinoma in situ: first results of the EORT randomised phase III trial 10853, Lancet, 355, 528, 10.1016\u002FS0140-6736(99)06341-2\nLiberman, 1994, Stereotaxic 14 gauges breast biopsy: how many core biopsy specimens are needed?, Radiology, 129, 793, 10.1148\u002Fradiology.192.3.8058949\nLiberman, 1995, Stereotaxic core biopsy of breast carcinoma accuracy at predicting invasion, Radiology, 194, 379, 10.1148\u002Fradiology.194.2.7824713\nLiberman, 2000, Imaging-histologic discordance at percutaneous breast biopsy, Cancer, 89, 2538, 10.1002\u002F1097-0142(20001215)89:12\u003C2538::AID-CNCR4>3.0.CO;2-#\nLiberman, 1997, Impact of core biopsy on the surgical management of impalpable breast cancer, AJR Am J Roentgenol, 168, 495, 10.2214\u002Fajr.168.2.9016234\nMcDivitt, 1967, In situ lobular carcinoma, JAMA, 201, 82, 10.1001\u002Fjama.1967.03130020028006\nMorrow, 2000, Ductal carcinoma in situ and micro-invasion carcinoma, 391\nOrel, 1997, MR imaging of ductal carcinoma in situ, Radiology, 202, 413, 10.1148\u002Fradiology.202.2.9015067\nOsborne, 1994, Current management of lobular carcinoma in situ of the breast, Oncology, 8, 45\nOttesen, 1991, Lobular carcinoma in situ of thefemale breast. Short-term results of a prospective nationwide study, Am J Surg Pathol, 17, 14, 10.1097\u002F00000478-199301000-00002\nPage, 1995, Continued local recurrence of carcinoma 15–25 years after a diagnosis of low-grade ductal carcinoma in situ of the breast treated only by biopsy, Cancer, 76, 1197, 10.1002\u002F1097-0142(19951001)76:7\u003C1197::AID-CNCR2820760715>3.0.CO;2-0\nPage, 1985, Atypical hyperplasia lesions of the female breast: a long-term follow-up study, Cancer, 55, 2698, 10.1002\u002F1097-0142(19850601)55:11\u003C2698::AID-CNCR2820551127>3.0.CO;2-A\nParker, 1990, Stereotactic breast biopsy with a biopsy gun, Radiology, 176, 741, 10.1148\u002Fradiology.176.3.2167501\nPoller, 1996, Use of a pronostic index for breast ductal carcinoma in situ: is excision margin status still the most crucial factor in predicting disease recurrence, J Pathol, 178, 6A\nPowles, 1998, Iterim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial, Lancet, 352, 98, 10.1016\u002FS0140-6736(98)05071-5\nRecht, 1998, The fourth EORTC DCIS consensus meeting. Conference report, Eur J Cancer, 34, 1664, 10.1016\u002FS0959-8049(98)00220-2\nRingberg, 1991, Breast carcinoma in situ in 167 women: incidence, mode of presentation, therapy and follow-up, Eur J Surg Oncol, 17, 466\nRosen, 1978, Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with average follow-up of 24 years, Am J Surg Pathol, 2, 225, 10.1097\u002F00000478-197809000-00001\nSchwartz, 1992, Subclinical ductal carcinoma in situ of the breast: treatment by local excision and surveillance alone, Cancer, 70, 2468, 10.1002\u002F1097-0142(19921115)70:10\u003C2468::AID-CNCR2820701013>3.0.CO;2-K\nSchwartz, 2000, The consensus conferenceon the treatment of in situ ductal carcinoma of the breast, Bull Cancer, 87, 499\nSilverstein, 1998, Ductal carcinoma in situ: controversal issues, 1044\nSilverstein, 1999, The influence of margin width on local control of ductal carcinoma in situ of the breast, N Engl J Med, 340, 1455, 10.1056\u002FNEJM199905133401902\nSilverstein, 1998, Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast, J Clin Oncol, 16, 1367, 10.1200\u002FJCO.1998.16.4.1367\nSimmons, 1999, The evaluation of high-risk and pre-invasive breast lesions and the decisions process for follow-up and surgical intervention, Surg Oncol, 8, 55, 10.1016\u002FS0960-7404(99)00030-4\nStomer, 1992, Ductal carcinoma in situ of the breast: correlation between mammographic calcifications and tumor subtype, AJR Am J Roentgenol, 159, 483, 10.2214\u002Fajr.159.3.1323923\nStyblo, 1999, The management of ductal and lobular breast cancer, Surg Oncol, 8, 67, 10.1016\u002FS0960-7404(99)00048-1\nSwain, 1989, Lobularcarcinoma in situ: incidence, presentation, guidelines to treatment, Oncology, 3, 35\nSwain, 1988, Intraepithelial carcinoma of the breast lobular carcinoma in situ and ductal carcinoma in situ, 296\nTabar, 1997, Mammographic appearances of in situ carcinomas, 95\nVelanovitch, 1999, Comparison of mammographicaily guided breast biopsy techniques, Ann Surg, 229, 625, 10.1097\u002F00000658-199905000-00004\nVeronesi, 1998, Prevention of breast cancer with tamoxifen: preliminary findings from the italian randomised trial among hysterectomised women: italian tamoxifen prevention study, Lancet, 352, 93, 10.1016\u002FS0140-6736(98)85011-3\nWeinreb, 1995, MR imaging of the breast, Radiology, 196, 593, 10.1148\u002Fradiology.196.3.7644617\nWheeler, 1974, Lobular carcinoma in situ of the breast, Cancer, 34, 554, 10.1002\u002F1097-0142(197409)34:3\u003C554::AID-CNCR2820340313>3.0.CO;2-7\nWinchester, 1998, Standards for diagnosis and management of ductal carcinoma in situ of the breast, CA Cancer J Clin, 48, 108, 10.3322\u002Fcanjclin.48.2.108\nWon, 1999, Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11 gauges vacuum-assisted device: persistent underestimation of disease, AJR Am J Roentgenol, 173, 227, 10.2214\u002Fajr.173.1.10397131\nWood, 1996, Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast, Semin Oncol, 23, 446",{"ES":1447},"Carcinoma mamario in situ",{"VOID":1449},"10.1016\u002Fs1283-081x(01)71893-0","2025-01-14T04:11:22.356+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X01718930",[1453],{"id":1454,"sortIndex":36,"researcher":26,"roles":1455,"affiliations":1456,"properties":1465},"69cd7e2c-0e2e-48ec-836f-d5d86937a167",[696],[1457],{"id":26,"sortIndex":36,"affiliation":1458,"properties":26},{"id":1459,"createTime":1460,"updateTime":1460,"relativeEntities":1461,"slug":26,"properties":1462,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1a6279ff-5418-4bfd-b5a3-65fe7cd8d80b","2024-01-12T08:48:08.402+00:00",[],{"title":1463},{"VI":1464},"Centre Oscar Lambret, 3, rue Frédéric-Combemale, 59020 Lille cedex, France",{"title":1466},{"VI":1467},"S. Giard",{"url":1451,"publisher":1469,"properties":1477},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1470,"slug":662,"properties":1471,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1474,"manageAffiliations":1475,"indexDatabases":1476,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1472,"title":1473},{"VOID":665},{"EN":667},[],[],[],{"volume":1478,"pages":1480},{"VOID":1479},"37",{"VOID":1481},"1-6","2001-01-01",2001,{"id":1485,"createTime":1486,"updateTime":1487,"relativeEntities":1488,"slug":1489,"properties":1490,"entityType":688,"verifyStatus":25,"verifyTime":1497,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1498,"fullTextUrl":26,"authors":1499,"publicationType":747,"publisherRelationship":1542,"citationCount":26,"citationInfo":26,"publishDate":1556,"publishYear":1557,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"a3fa7cab-efc4-4cc1-8a30-32af3cb09b70","2024-01-29T05:46:36.823+00:00","2024-12-17T05:43:02.879+00:00",[],"Histerectom%C3%ADa-por-v%C3%ADa-abdominal-por-lesiones-benignas",{"references":1491,"title":1493,"doi":1495},{"VOID":1492},"Carlson, 1993, Indications for hysterectomy, N. Engl. J. Med., 328, 856, 10.1056\u002FNEJM199303253281207\nCosson, 1997\nSubtil, 1997, Épidémiologie des hystérectomies, 151\nMcPherson, 2004, Severe complications of hysterectomy: the VALUE study, BJOG, 111, 688, 10.1111\u002Fj.1471-0528.2004.00174.x\nVillet, 1986, 164\nFlory, 2006, The psychosocial outcomes of total and subtotal hysterectomy: a randomized controlled trial, J. Sex. Med., 3, 483, 10.1111\u002Fj.1743-6109.2006.00229.x\nJohnson, 2005, Methods of hysterectomy: systematic review and meta-analysis of randomised controlled trials, BMJ, 330, 1478, 10.1136\u002Fbmj.330.7506.1478\nDavid-Montefiore, 2007, Surgical routes and complications of hysterectomy for benign disorders: a prospective observational study in French university hospitals, Hum. Reprod., 22, 260, 10.1093\u002Fhumrep\u002Fdel336\nPerineau, 1992, Complications of hysterectomies, Rev. Fr. Gynecol. Obstet., 87, 120\nMiskry, 2003, Randomized, prospective, double-blind comparison of abdominal and vaginal hysterectomy in women without uterovaginal prolapse, Acta Obstet. Gynecol. Scand., 82, 351, 10.1034\u002Fj.1600-0412.2003.00115.x\nCosson, 2001, Long-term complications of vaginal hysterectomy: a case control study, Eur. J. Obstet. Gynecol. Reprod. Biol., 94, 239, 10.1016\u002FS0301-2115(00)00339-0\nDebodinance, 2000, Comparison of the Bologna and Ingelman-Sundberg procedures for stress incontinence associated with genital prolapse: ten-year follow-up of a prospective randomized study, J. Gynecol. Obstet. Biol. Reprod. (Paris), 29, 148\nKovac, 2000, Hysterectomy outcomes in patients with similar indications, Obstet. Gynecol., 95, 787\nMarana, 1999, Laparoscopically assisted vaginal hysterectomy versus total abdominal hysterectomy: a prospective, randomized, multicenter study, Am. J. Obstet. Gynecol., 180, 270, 10.1016\u002FS0002-9378(99)70199-7\nBenassi, 2002, Abdominal or vaginal hysterectomy for enlarged uteri: a randomized clinical trial, Am. J. Obstet. Gynecol., 187, 1561, 10.1067\u002Fmob.2002.127596\nLanger, 1989, The effect of total abdominal hysterectomy on bladder function in asymptomatic women, Obstet. Gynecol., 74, 205\nVervest, 1989, Non-radical hysterectomy and the function of the lower urinary tract. II: Urodynamic quantification of changes in evacuation function, Acta Obstet. Gynecol. Scand., 68, 231, 10.3109\u002F00016348909020994\nSmith, 1990, Disordered colorectal motility in intractable constipation following hysterectomy, Br. J. Surg., 77, 1361, 10.1002\u002Fbjs.1800771214\nHeaton, 1993, Bowel function and irritable bowel symptoms after hysterectomy and cholecystectomy--a population based study, Gut, 34, 1108, 10.1136\u002Fgut.34.8.1108\nTaylor, 1990, Effects of hysterectomy on bowel and bladder function, Int. J. Colorectal Dis., 5, 228, 10.1007\u002FBF00303282\nLonnee-Hoffmann, 2006, Sexual experience of partners after hysterectomy, comparing subtotal with total abdominal hysterectomy, Acta Obstet. Gynecol. Scand., 85, 1389, 10.1080\u002F00016340600917316\nMokate, 2006, Hysterectomy and sexual function, J. Br. Menopause Soc., 12, 153, 10.1258\u002F136218006779160607\nMonroy-Lozano, 2006, Dyspareunia after total abdominal hysterectomy. Anatomical relation, Cir. Cir., 74, 257\nSchofield, 1991, Self-reported long-term outcomes of hysterectomy, Br. J. Obstet. Gynaecol., 98, 1129, 10.1111\u002Fj.1471-0528.1991.tb15365.x\nKuppermann, 2004, Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial, JAMA, 291, 1447, 10.1001\u002Fjama.291.12.1447",{"ES":1494},"Histerectomía por vía abdominal por lesiones benignas",{"VOID":1496},"10.1016\u002Fs1283-081x(09)70786-6","2024-12-17T05:43:02.878+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X09707866",[1500,1515,1530],{"id":1501,"sortIndex":36,"researcher":26,"roles":1502,"affiliations":1503,"properties":1512},"883b42b1-48b2-4f70-bff0-022de4a8a437",[696],[1504],{"id":26,"sortIndex":36,"affiliation":1505,"properties":26},{"id":1506,"createTime":1507,"updateTime":1507,"relativeEntities":1508,"slug":26,"properties":1509,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"3b241b0d-9ca2-403d-8622-f33e645340b5","2024-01-29T05:46:36.836+00:00",[],{"title":1510},{"VI":1511},"Service de chirurgie gynécologique, Hôpital Jeanne de Flandre, 2, avenue Oscar-Lambret, 59 000 Lille, France",{"title":1513},{"VI":1514},"F. Sabban",{"id":1516,"sortIndex":114,"researcher":26,"roles":1517,"affiliations":1518,"properties":1527},"3a102a15-d618-472e-b129-ba3e0af4cd2a",[696],[1519],{"id":26,"sortIndex":36,"affiliation":1520,"properties":26},{"id":1521,"createTime":1522,"updateTime":1522,"relativeEntities":1523,"slug":26,"properties":1524,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"12e5431b-0d79-48b2-9981-a345b7543c6a","2024-01-29T05:46:36.861+00:00",[],{"title":1525},{"VI":1526},"Professeur au Collège de médecine, chef du service de chirurgie générale et gynécologique, Hôpital des Diaconesses, 18, rue du Sergent-Beauchat, 75012 Paris, France",{"title":1528},{"VI":1529},"R. Villet",{"id":1531,"sortIndex":115,"researcher":26,"roles":1532,"affiliations":1533,"properties":1539},"296a2e1f-9863-4b85-a685-b9e3c2aa7506",[696],[1534],{"id":26,"sortIndex":36,"affiliation":1535,"properties":26},{"id":1506,"createTime":1507,"updateTime":1507,"relativeEntities":1536,"slug":26,"properties":1537,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1538},{"VI":1511},{"title":1540},{"VI":1541},"P. Collinet",{"url":1498,"publisher":1543,"properties":1551},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1544,"slug":662,"properties":1545,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1548,"manageAffiliations":1549,"indexDatabases":1550,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1546,"title":1547},{"VOID":665},{"EN":667},[],[],[],{"volume":1552,"pages":1554},{"VOID":1553},"45",{"VOID":1555},"1-9","2009-01-01",2009]